US5296214A - Anticalculus composition - Google Patents
Anticalculus composition Download PDFInfo
- Publication number
- US5296214A US5296214A US07/925,363 US92536392A US5296214A US 5296214 A US5296214 A US 5296214A US 92536392 A US92536392 A US 92536392A US 5296214 A US5296214 A US 5296214A
- Authority
- US
- United States
- Prior art keywords
- oral composition
- weight
- amount
- agent
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 230000002272 anti-calculus Effects 0.000 title description 6
- 239000000551 dentifrice Substances 0.000 claims abstract description 56
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 52
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 31
- 230000002882 anti-plaque Effects 0.000 claims abstract description 19
- 229920002554 vinyl polymer Polymers 0.000 claims abstract description 13
- 239000002324 mouth wash Substances 0.000 claims abstract description 11
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 claims abstract description 10
- 229940051866 mouthwash Drugs 0.000 claims abstract description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 53
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 38
- 239000000463 material Substances 0.000 claims description 38
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 36
- 238000005498 polishing Methods 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- -1 hydrogen alkali metal Chemical class 0.000 claims description 26
- 239000003921 oil Substances 0.000 claims description 17
- 235000019198 oils Nutrition 0.000 claims description 17
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000377 silicon dioxide Substances 0.000 claims description 15
- 239000004094 surface-active agent Substances 0.000 claims description 15
- 239000002904 solvent Substances 0.000 claims description 14
- 239000003981 vehicle Substances 0.000 claims description 14
- 230000000844 anti-bacterial effect Effects 0.000 claims description 13
- 239000002562 thickening agent Substances 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 231100000252 nontoxic Toxicity 0.000 claims description 8
- 230000003000 nontoxic effect Effects 0.000 claims description 8
- 210000003296 saliva Anatomy 0.000 claims description 8
- 229910052783 alkali metal Inorganic materials 0.000 claims description 7
- 239000001506 calcium phosphate Substances 0.000 claims description 7
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 claims description 6
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical group O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 claims description 6
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 5
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 5
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 5
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 5
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical class C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 4
- 230000002708 enhancing effect Effects 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 3
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims description 3
- 229940072049 amyl acetate Drugs 0.000 claims description 3
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 claims description 3
- 229960002903 benzyl benzoate Drugs 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 3
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 claims description 3
- 229940051250 hexylene glycol Drugs 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 150000002989 phenols Chemical class 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- UVGZJJKEELPWRH-JSCKKFHOSA-M potassium (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoate Chemical compound [K+].O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C([O-])=O UVGZJJKEELPWRH-JSCKKFHOSA-M 0.000 claims description 3
- 235000019983 sodium metaphosphate Nutrition 0.000 claims description 3
- 208000002064 Dental Plaque Diseases 0.000 claims description 2
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 230000007505 plaque formation Effects 0.000 claims description 2
- 230000003381 solubilizing effect Effects 0.000 claims description 2
- 239000000375 suspending agent Substances 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000008135 aqueous vehicle Substances 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 claims 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 claims 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 abstract description 40
- 229960003500 triclosan Drugs 0.000 abstract description 39
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 20
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 19
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 19
- 239000000600 sorbitol Substances 0.000 description 19
- 235000019441 ethanol Nutrition 0.000 description 18
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 18
- 235000013772 propylene glycol Nutrition 0.000 description 16
- 238000002360 preparation method Methods 0.000 description 15
- 239000000499 gel Substances 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 14
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 13
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 13
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 12
- 239000003906 humectant Substances 0.000 description 10
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 10
- 239000011775 sodium fluoride Substances 0.000 description 9
- 235000013024 sodium fluoride Nutrition 0.000 description 9
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 8
- AQMNWCRSESPIJM-UHFFFAOYSA-M sodium metaphosphate Chemical compound [Na+].[O-]P(=O)=O AQMNWCRSESPIJM-UHFFFAOYSA-M 0.000 description 8
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 8
- 239000012071 phase Substances 0.000 description 7
- 229960003742 phenol Drugs 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 229920000388 Polyphosphate Polymers 0.000 description 6
- 125000000129 anionic group Chemical group 0.000 description 6
- 239000001768 carboxy methyl cellulose Substances 0.000 description 6
- 239000001205 polyphosphate Substances 0.000 description 6
- 235000011176 polyphosphates Nutrition 0.000 description 6
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 6
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 6
- 239000004408 titanium dioxide Substances 0.000 description 6
- 239000000606 toothpaste Substances 0.000 description 6
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000679 carrageenan Substances 0.000 description 5
- 229920001525 carrageenan Polymers 0.000 description 5
- 229940113118 carrageenan Drugs 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 4
- 239000005770 Eugenol Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 4
- 239000005844 Thymol Substances 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 229960002217 eugenol Drugs 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000003349 gelling agent Substances 0.000 description 4
- 208000007565 gingivitis Diseases 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 229960000790 thymol Drugs 0.000 description 4
- 229940034610 toothpaste Drugs 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- LVLNPXCISNPHLE-UHFFFAOYSA-N 2-[(4-hydroxyphenyl)methyl]phenol Chemical compound C1=CC(O)=CC=C1CC1=CC=CC=C1O LVLNPXCISNPHLE-UHFFFAOYSA-N 0.000 description 3
- TYBHZVUFOINFDV-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol Chemical compound OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O TYBHZVUFOINFDV-UHFFFAOYSA-N 0.000 description 3
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008119 colloidal silica Substances 0.000 description 3
- 239000007859 condensation product Substances 0.000 description 3
- 210000003298 dental enamel Anatomy 0.000 description 3
- 229940091249 fluoride supplement Drugs 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 125000005341 metaphosphate group Chemical group 0.000 description 3
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 2
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 2
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 2
- HXDOZKJGKXYMEW-UHFFFAOYSA-N 4-ethylphenol Chemical compound CCC1=CC=C(O)C=C1 HXDOZKJGKXYMEW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- 229920002582 Polyethylene Glycol 600 Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- VYKKDKFTDMVOBU-UHFFFAOYSA-N flusalan Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=CC(C(F)(F)F)=C1 VYKKDKFTDMVOBU-UHFFFAOYSA-N 0.000 description 2
- 229910001679 gibbsite Inorganic materials 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229940094522 laponite Drugs 0.000 description 2
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- KZNNRLXBDAAMDZ-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane trihydrate Chemical compound O.O.O.O=[Al]O[Al]=O KZNNRLXBDAAMDZ-UHFFFAOYSA-N 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 2
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 2
- VSJRDSLPNMGNFG-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate;trihydrate Chemical compound O.O.O.[Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O VSJRDSLPNMGNFG-UHFFFAOYSA-H 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229940085658 zinc citrate trihydrate Drugs 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- BYOBJKVGOIXVED-UHFFFAOYSA-N (2-phosphonoazepan-2-yl)phosphonic acid Chemical compound OP(O)(=O)C1(P(O)(O)=O)CCCCCN1 BYOBJKVGOIXVED-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RPZANUYHRMRTTE-UHFFFAOYSA-N 2,3,4-trimethoxy-6-(methoxymethyl)-5-[3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxyoxane;1-[[3,4,5-tris(2-hydroxybutoxy)-6-[4,5,6-tris(2-hydroxybutoxy)-2-(2-hydroxybutoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]butan-2-ol Chemical compound COC1C(OC)C(OC)C(COC)OC1OC1C(OC)C(OC)C(OC)OC1COC.CCC(O)COC1C(OCC(O)CC)C(OCC(O)CC)C(COCC(O)CC)OC1OC1C(OCC(O)CC)C(OCC(O)CC)C(OCC(O)CC)OC1COCC(O)CC RPZANUYHRMRTTE-UHFFFAOYSA-N 0.000 description 1
- KUFFULVDNCHOFZ-UHFFFAOYSA-N 2,4-xylenol Chemical compound CC1=CC=C(O)C(C)=C1 KUFFULVDNCHOFZ-UHFFFAOYSA-N 0.000 description 1
- WFGFKMBPJVVHDC-UHFFFAOYSA-N 2,5-dimethylphenol 3,4-dimethylphenol Chemical compound CC=1C=C(C=CC1C)O.CC1=C(C=C(C=C1)C)O WFGFKMBPJVVHDC-UHFFFAOYSA-N 0.000 description 1
- CFSOXRGHLCXRNB-UHFFFAOYSA-N 2-(3-phenylpropyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCCC1=CC=CC=C1 CFSOXRGHLCXRNB-UHFFFAOYSA-N 0.000 description 1
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical class CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 description 1
- NGOZDSMNMIRDFP-UHFFFAOYSA-N 2-[methyl(tetradecanoyl)amino]acetic acid Chemical class CCCCCCCCCCCCCC(=O)N(C)CC(O)=O NGOZDSMNMIRDFP-UHFFFAOYSA-N 0.000 description 1
- GXJQMKFJQFGQKV-KHPPLWFESA-N 2-[methyl-[(z)-octadec-9-enoyl]amino]ethanesulfonic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)N(C)CCS(O)(=O)=O GXJQMKFJQFGQKV-KHPPLWFESA-N 0.000 description 1
- IYXUFNCIWJHFBR-UHFFFAOYSA-N 2-benzyl-4-chloro-3-methylphenol Chemical compound CC1=C(Cl)C=CC(O)=C1CC1=CC=CC=C1 IYXUFNCIWJHFBR-UHFFFAOYSA-N 0.000 description 1
- WPMBXQJYQZTSGS-UHFFFAOYSA-N 2-benzyl-4-chlorobenzene-1,3-diol Chemical compound OC1=CC=C(Cl)C(O)=C1CC1=CC=CC=C1 WPMBXQJYQZTSGS-UHFFFAOYSA-N 0.000 description 1
- RKDMDAVSHRCXQZ-UHFFFAOYSA-N 2-benzylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CC1=CC=CC=C1 RKDMDAVSHRCXQZ-UHFFFAOYSA-N 0.000 description 1
- KSDMMSMHJOPTSY-UHFFFAOYSA-N 2-bromo-3-(2-methylbutan-2-yl)phenol Chemical compound CCC(C)(C)C1=CC=CC(O)=C1Br KSDMMSMHJOPTSY-UHFFFAOYSA-N 0.000 description 1
- COVGKJSMQVFLDP-UHFFFAOYSA-N 2-bromo-3-hexylphenol Chemical compound CCCCCCC1=CC=CC(O)=C1Br COVGKJSMQVFLDP-UHFFFAOYSA-N 0.000 description 1
- ZIYRDJLAJYTELF-UHFFFAOYSA-N 2-bromo-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1Br ZIYRDJLAJYTELF-UHFFFAOYSA-N 0.000 description 1
- LHEJAFZNZALXJK-UHFFFAOYSA-N 2-bromo-6-[(3-bromo-5-chloro-2-hydroxyphenyl)methyl]-4-chlorophenol;4-chloro-2-[(5-chloro-2-hydroxyphenyl)methylsulfanylmethyl]phenol;2,4-dichloro-6-(3,5-dichloro-2-hydroxyphenyl)sulfanylphenol Chemical compound OC1=CC=C(Cl)C=C1CSCC1=CC(Cl)=CC=C1O.OC1=C(Br)C=C(Cl)C=C1CC1=CC(Cl)=CC(Br)=C1O.OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O LHEJAFZNZALXJK-UHFFFAOYSA-N 0.000 description 1
- BRYHBLAGEXUHSL-UHFFFAOYSA-N 2-butan-2-yl-4-chloro-5-methylphenol Chemical compound CCC(C)C1=CC(Cl)=C(C)C=C1O BRYHBLAGEXUHSL-UHFFFAOYSA-N 0.000 description 1
- COSYXLHTXXMVGM-UHFFFAOYSA-N 2-butyl-4-chlorophenol Chemical compound CCCCC1=CC(Cl)=CC=C1O COSYXLHTXXMVGM-UHFFFAOYSA-N 0.000 description 1
- CPFCAXZZIBOLNU-UHFFFAOYSA-N 2-chloro-3-(2-methylbutan-2-yl)phenol;2-chlorophenol Chemical compound OC1=CC=CC=C1Cl.CCC(C)(C)C1=CC=CC(O)=C1Cl CPFCAXZZIBOLNU-UHFFFAOYSA-N 0.000 description 1
- UNRRZPJVYQDQPL-UHFFFAOYSA-N 2-chloro-3-ethylphenol Chemical compound CCC1=CC=CC(O)=C1Cl UNRRZPJVYQDQPL-UHFFFAOYSA-N 0.000 description 1
- CPYVNEMCZOXHDI-UHFFFAOYSA-N 2-chloro-3-heptylphenol;4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1.CCCCCCCC1=CC=CC(O)=C1Cl CPYVNEMCZOXHDI-UHFFFAOYSA-N 0.000 description 1
- PFEPQLAKIAJJRQ-UHFFFAOYSA-N 2-chloro-3-hexylphenol Chemical compound CCCCCCC1=CC=CC(O)=C1Cl PFEPQLAKIAJJRQ-UHFFFAOYSA-N 0.000 description 1
- KHWKJUTXTSNBKW-UHFFFAOYSA-N 2-chloro-3-propylphenol Chemical compound CCCC1=CC=CC(O)=C1Cl KHWKJUTXTSNBKW-UHFFFAOYSA-N 0.000 description 1
- DWVXFVWWARTDCQ-UHFFFAOYSA-N 2-ethylbenzene-1,3-diol Chemical compound CCC1=C(O)C=CC=C1O DWVXFVWWARTDCQ-UHFFFAOYSA-N 0.000 description 1
- GOUWRHHYANYVLG-UHFFFAOYSA-N 2-heptylbenzene-1,3-diol Chemical compound CCCCCCCC1=C(O)C=CC=C1O GOUWRHHYANYVLG-UHFFFAOYSA-N 0.000 description 1
- UOWIFEANNONTKY-UHFFFAOYSA-N 2-hydroxy-5-octanoyl-n-[3-(trifluoromethyl)phenyl]benzamide Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(=O)NC=2C=C(C=CC=2)C(F)(F)F)=C1 UOWIFEANNONTKY-UHFFFAOYSA-N 0.000 description 1
- LMWMTSCFTPQVCJ-UHFFFAOYSA-N 2-methylphenol;phenol Chemical compound OC1=CC=CC=C1.CC1=CC=CC=C1O LMWMTSCFTPQVCJ-UHFFFAOYSA-N 0.000 description 1
- IEIHCSFJLQYKGJ-UHFFFAOYSA-N 2-nonylbenzene-1,3-diol Chemical compound CCCCCCCCCC1=C(O)C=CC=C1O IEIHCSFJLQYKGJ-UHFFFAOYSA-N 0.000 description 1
- HHSCZZZCAYSVRK-UHFFFAOYSA-N 2-octylbenzene-1,3-diol Chemical compound CCCCCCCCC1=C(O)C=CC=C1O HHSCZZZCAYSVRK-UHFFFAOYSA-N 0.000 description 1
- UPXZHXVOMCGZDS-UHFFFAOYSA-N 2-phenylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1C1=CC=CC=C1 UPXZHXVOMCGZDS-UHFFFAOYSA-N 0.000 description 1
- XDCMHOFEBFTMNL-UHFFFAOYSA-N 2-propylbenzene-1,3-diol Chemical compound CCCC1=C(O)C=CC=C1O XDCMHOFEBFTMNL-UHFFFAOYSA-N 0.000 description 1
- WLYIIDKKPCXCLS-UHFFFAOYSA-N 3,4,5-tribromo-2-hydroxy-n-phenylbenzamide Chemical compound OC1=C(Br)C(Br)=C(Br)C=C1C(=O)NC1=CC=CC=C1 WLYIIDKKPCXCLS-UHFFFAOYSA-N 0.000 description 1
- YJESMCOKCBFYBX-UHFFFAOYSA-N 3,5,6-trichloro-n-(3-chlorophenyl)-6-hydroxycyclohexa-2,4-diene-1-carboxamide Chemical compound C1=C(Cl)C=C(Cl)C(O)(Cl)C1C(=O)NC1=CC=CC(Cl)=C1 YJESMCOKCBFYBX-UHFFFAOYSA-N 0.000 description 1
- FLYZSJGIJYEAFV-UHFFFAOYSA-N 3,5-dibromo-2-hydroxy-n-[4-(trifluoromethyl)phenyl]benzamide Chemical compound OC1=C(Br)C=C(Br)C=C1C(=O)NC1=CC=C(C(F)(F)F)C=C1 FLYZSJGIJYEAFV-UHFFFAOYSA-N 0.000 description 1
- OAOFCENSKJNHQG-UHFFFAOYSA-N 3-butyl-2-chlorophenol Chemical compound CCCCC1=CC=CC(O)=C1Cl OAOFCENSKJNHQG-UHFFFAOYSA-N 0.000 description 1
- PQSXNIMHIHYFEE-UHFFFAOYSA-N 4-(1-phenylethyl)benzene-1,3-diol Chemical compound C=1C=C(O)C=C(O)C=1C(C)C1=CC=CC=C1 PQSXNIMHIHYFEE-UHFFFAOYSA-N 0.000 description 1
- KLSLBUSXWBJMEC-UHFFFAOYSA-N 4-Propylphenol Chemical compound CCCC1=CC=C(O)C=C1 KLSLBUSXWBJMEC-UHFFFAOYSA-N 0.000 description 1
- ATVXBMXBDVUKPM-UHFFFAOYSA-N 4-bromo-2-butylphenol Chemical compound CCCCC1=CC(Br)=CC=C1O ATVXBMXBDVUKPM-UHFFFAOYSA-N 0.000 description 1
- MAAADQMBQYSOOG-UHFFFAOYSA-N 4-bromo-2-ethylphenol Chemical compound CCC1=CC(Br)=CC=C1O MAAADQMBQYSOOG-UHFFFAOYSA-N 0.000 description 1
- NBJOEVNMBJIEBA-UHFFFAOYSA-N 4-bromo-2-hexylphenol Chemical compound CCCCCCC1=CC(Br)=CC=C1O NBJOEVNMBJIEBA-UHFFFAOYSA-N 0.000 description 1
- AEHYMMFSHCSYAA-UHFFFAOYSA-N 4-bromo-2-propylphenol Chemical compound CCCC1=CC(Br)=CC=C1O AEHYMMFSHCSYAA-UHFFFAOYSA-N 0.000 description 1
- KRGQEXZPJZOFLE-UHFFFAOYSA-N 4-chloro-2-[(5-chloro-2-hydroxyphenyl)methyl]phenol 3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O.OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl KRGQEXZPJZOFLE-UHFFFAOYSA-N 0.000 description 1
- WBQFGBDPSGGESL-UHFFFAOYSA-N 4-chloro-2-ethyl-3,5-dimethylphenol Chemical compound CCC1=C(C)C(Cl)=C(C)C=C1O WBQFGBDPSGGESL-UHFFFAOYSA-N 0.000 description 1
- ZSTDEWVWZHPUCW-UHFFFAOYSA-N 4-chloro-2-ethyl-5-methylphenol Chemical compound CCC1=CC(Cl)=C(C)C=C1O ZSTDEWVWZHPUCW-UHFFFAOYSA-N 0.000 description 1
- QCEDDUSMBLCRNH-UHFFFAOYSA-N 4-chloro-2-ethylphenol Chemical compound CCC1=CC(Cl)=CC=C1O QCEDDUSMBLCRNH-UHFFFAOYSA-N 0.000 description 1
- RHPUJHQBPORFGV-UHFFFAOYSA-N 4-chloro-2-methylphenol Chemical compound CC1=CC(Cl)=CC=C1O RHPUJHQBPORFGV-UHFFFAOYSA-N 0.000 description 1
- GLXDMSOEJKXENG-UHFFFAOYSA-N 4-chloro-2-propylphenol Chemical compound CCCC1=CC(Cl)=CC=C1O GLXDMSOEJKXENG-UHFFFAOYSA-N 0.000 description 1
- HFHNPIHVXJLWNW-UHFFFAOYSA-N 4-chloro-3,5-dimethyl-2-pentan-2-ylphenol Chemical compound CCCC(C)C1=C(C)C(Cl)=C(C)C=C1O HFHNPIHVXJLWNW-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- FDFTZPSQIKUAMS-UHFFFAOYSA-N 4-chloro-3-methyl-2-(2-phenylethyl)phenol Chemical compound CC1=C(Cl)C=CC(O)=C1CCC1=CC=CC=C1 FDFTZPSQIKUAMS-UHFFFAOYSA-N 0.000 description 1
- KFZXVMNBUMVKLN-UHFFFAOYSA-N 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC(Cl)=C(C)C=C1O KFZXVMNBUMVKLN-UHFFFAOYSA-N 0.000 description 1
- PBDKPFIVQQUKMK-UHFFFAOYSA-N 4-chloro-5-methyl-2-propylphenol Chemical compound CCCC1=CC(Cl)=C(C)C=C1O PBDKPFIVQQUKMK-UHFFFAOYSA-N 0.000 description 1
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 1
- MNVMYTVDDOXZLS-UHFFFAOYSA-N 4-methoxyguaiacol Natural products COC1=CC=C(O)C(OC)=C1 MNVMYTVDDOXZLS-UHFFFAOYSA-N 0.000 description 1
- CYYZDBDROVLTJU-UHFFFAOYSA-N 4-n-Butylphenol Chemical compound CCCCC1=CC=C(O)C=C1 CYYZDBDROVLTJU-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- SZWBRVPZWJYIHI-UHFFFAOYSA-N 4-n-Hexylphenol Chemical compound CCCCCCC1=CC=C(O)C=C1 SZWBRVPZWJYIHI-UHFFFAOYSA-N 0.000 description 1
- ZNPSUQQXTRRSBM-UHFFFAOYSA-N 4-n-Pentylphenol Chemical compound CCCCCC1=CC=C(O)C=C1 ZNPSUQQXTRRSBM-UHFFFAOYSA-N 0.000 description 1
- DDFHBQSCUXNBSA-UHFFFAOYSA-N 5-(5-carboxythiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(C(O)=O)S1 DDFHBQSCUXNBSA-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- KZHMXWCJVAQSRH-UHFFFAOYSA-N 5-methyl-2-pentylphenol;3-methyl-4-propan-2-ylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C.CCCCCC1=CC=C(C)C=C1O KZHMXWCJVAQSRH-UHFFFAOYSA-N 0.000 description 1
- IOAISUCAQCEHTA-UHFFFAOYSA-N 5-methyl-2-propan-2-ylphenol Chemical compound CC(C)C1=CC=C(C)C=C1O.CC(C)C1=CC=C(C)C=C1O IOAISUCAQCEHTA-UHFFFAOYSA-N 0.000 description 1
- 229910018626 Al(OH) Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- RMMNHBRHVZWYGS-UHFFFAOYSA-N BrC1=C(C=CC=C1)O.C1(CCCCC1)C1=C(C=CC(=C1)Br)O Chemical compound BrC1=C(C=CC=C1)O.C1(CCCCC1)C1=C(C=CC(=C1)Br)O RMMNHBRHVZWYGS-UHFFFAOYSA-N 0.000 description 1
- SYNDHPGTYQWXIS-UHFFFAOYSA-N C(C)(CCCCCC)C1=CC(=C(C=C1O)C)Cl.ClC1=CC=C(C=C1)O Chemical compound C(C)(CCCCCC)C1=CC(=C(C=C1O)C)Cl.ClC1=CC=C(C=C1)O SYNDHPGTYQWXIS-UHFFFAOYSA-N 0.000 description 1
- IJSNYIGWJAFFKY-UHFFFAOYSA-N C(CCCCC)C1=C(C=CC(=C1)Cl)O.ClC1=CC=C(C=C1)O Chemical compound C(CCCCC)C1=C(C=CC(=C1)Cl)O.ClC1=CC=C(C=C1)O IJSNYIGWJAFFKY-UHFFFAOYSA-N 0.000 description 1
- HXSMWMUGBRYSJC-UHFFFAOYSA-N C(CCCCC)C1=C(O)C=CC=C1O.C1(O)=CC(O)=CC=C1 Chemical compound C(CCCCC)C1=C(O)C=CC=C1O.C1(O)=CC(O)=CC=C1 HXSMWMUGBRYSJC-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- WUEGYEDRWKJKTI-UHFFFAOYSA-N ClC1=C(C=C(C(=C1C)Cl)C)O.ClC1=C(C=C(C=C1C)O)C.ClC1=C(C=C(C=C1)O)C Chemical compound ClC1=C(C=C(C(=C1C)Cl)C)O.ClC1=C(C=C(C=C1C)O)C.ClC1=C(C=C(C=C1)O)C WUEGYEDRWKJKTI-UHFFFAOYSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- 229910021593 Copper(I) fluoride Inorganic materials 0.000 description 1
- 229910021594 Copper(II) fluoride Inorganic materials 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 239000005696 Diammonium phosphate Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910011763 Li2 O Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 235000014749 Mentha crispa Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229910004742 Na2 O Inorganic materials 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 229920001807 Urea-formaldehyde Polymers 0.000 description 1
- 229920006387 Vinylite Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical class [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940027983 antiseptic and disinfectant quaternary ammonium compound Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 150000003976 azacycloalkanes Chemical class 0.000 description 1
- OYLGJCQECKOTOL-UHFFFAOYSA-L barium fluoride Chemical compound [F-].[F-].[Ba+2] OYLGJCQECKOTOL-UHFFFAOYSA-L 0.000 description 1
- 229910001632 barium fluoride Inorganic materials 0.000 description 1
- GORPMJOSUHSODZ-UHFFFAOYSA-N benzene-1,3-diol;2-methylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1.CC1=C(O)C=CC=C1O GORPMJOSUHSODZ-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- GWFAVIIMQDUCRA-UHFFFAOYSA-L copper(ii) fluoride Chemical compound [F-].[F-].[Cu+2] GWFAVIIMQDUCRA-UHFFFAOYSA-L 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 239000003975 dentin desensitizing agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229910000388 diammonium phosphate Inorganic materials 0.000 description 1
- 235000019838 diammonium phosphate Nutrition 0.000 description 1
- DGTVXEHQMSJRPE-UHFFFAOYSA-N difluorophosphinic acid Chemical compound OP(F)(F)=O DGTVXEHQMSJRPE-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical class CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940093499 ethyl acetate Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002193 fatty amides Chemical class 0.000 description 1
- 150000004673 fluoride salts Chemical class 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910001506 inorganic fluoride Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-methyl-PhOH Natural products CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- NZEKLJZFMLILAA-UHFFFAOYSA-N n-(3,4-dibromophenyl)-2-hydroxybenzamide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=C(Br)C(Br)=C1 NZEKLJZFMLILAA-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229940041672 oral gel Drugs 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 229940106025 phenylethyl resorcinol Drugs 0.000 description 1
- 125000005499 phosphonyl group Chemical group 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical class C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- UGTZMIPZNRIWHX-UHFFFAOYSA-K sodium trimetaphosphate Chemical compound [Na+].[Na+].[Na+].[O-]P1(=O)OP([O-])(=O)OP([O-])(=O)O1 UGTZMIPZNRIWHX-UHFFFAOYSA-K 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 101150035983 str1 gene Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical class [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 150000003752 zinc compounds Chemical class 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8117—Homopolymers or copolymers of aromatic olefines, e.g. polystyrene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8164—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical, and containing at least one other carboxyl radical in the molecule, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers, e.g. poly (methyl vinyl ether-co-maleic anhydride)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- This invention relates to an antibacterial antiplaque oral compositions such as dentifrices and mouthwashes. More particularly, it relates to oral compositions containing a substantially water-insoluble noncationic antibacterial agent effective to inhibit plaque.
- Dental plaque is a soft deposit which forms on teeth as opposed to calculus which is a hard calcified deposit on teeth. Unlike calculus, plaque may form on any part of the tooth surface, particularly including at the gingival margin. Hence, besides being unsightly, it is implicated in the occurrence of gingivitis.
- antimicrobial agents which have been known to reduce plaque in oral compositions.
- cationic antibacterial agents have been suggested.
- a compound providing zinc ions as an anticalculus agent is admixed with an antibacterial agent effective to retard the growth of plaque bacteria.
- antibacterial agents are described with the zinc compounds including cationic materials such as guanides and quaternary ammonium compounds as well as non-cationic compounds such as halogenated salicylanilides and halogenated hydroxydiphenyl ethers.
- noncationic antibacterial antiplaque halogenated hydroxydiphenyl ether has also been described in combination with zinc citrate trihydrate in European Patent 0161,899 to Saxton et al.
- Triclosan is also disclosed in European Patent Publication 0271,332 to Davis as a toothpaste component containing a solubilizing agent such as propylene glycol and in PCT Publication WD 92/00721 to Read in combination with azacycloalkane diphosphonates.
- cationic antibacterial materials such as chlorhexidine, benzthonium chloride and cetyl pyridinium chloride have been the subject of greatest investigation as antibacterial antiplaque agents. However, they are generally not effective when used with anionic materials.
- Noncationic antibacterial materials can be compatible with anionic components in an oral composition.
- oral compositions typically are mixtures of numerous components and even such typically neutral materials as humectants can affect performance of such compositions.
- noncationic antibacterial agents may have limited antiplaque effectiveness with commonly used materials such as polyphosphate anticalculus agents which are disclosed together in British Patent Publication 22 00551 of Gaffar et al and in EP 0251591 of Jackson et al.
- an oral composition comprising a substantially water. insoluble noncationic antibacterial agent wherein polyvinyl phosphonate (PVPA) enhances the antibacterial effect of the antibacterial agent to inhibit plaque formation, wherein the oral composition contains an orally acceptable liquid vehicle effective to enable said antibacterial agent to dissolve in saliva in effective antiplaque amount.
- PVPA polyvinyl phosphonate
- an antiplaque oral composition is provided which is effective to reduce the occurrence of gingivitis.
- this invention relates to an oral composition
- an effective antiplaque amount of a substantially water insoluble noncationic antibacterial agent at least about 0.005% by weight of polyvinyl phosphonate having recurring groups ##STR1## and average molecular weight of at least about 1,000 and wherein M and M 1 are hydrogen, alkali metal or ammonium and wherein M and M 1 are the same or different and an orally acceptable vehicle comprising at least one of a surface-active agent or a flavoring oil effective to enable said antibacterial agent to dissolve in saliva in effective antiplaque amount.
- Typical examples of water insoluble noncationic antibacterial agents which are particularly desirable from considerations of antiplaque effectiveness, safety and formulation are:
- Phenolic Compounds including phenol and its homoglogs, mono- and poly-alkyl and aromatic halo (e.g., Cl, Br, I)-phenols, resorcinol and catechol and their derivatives and bisphenolic compounds.
- aromatic halo e.g., Cl, Br, I
- Such compounds include inter alia:
- the noncationic antibacterial agent is present in the composition of the present invention in an effective antiplaque amount, preferably about 0.01-5% by weight, more preferably about 0.25-0.5% or about 0.05 to less than 0.5% and most preferably about 0.25-0.35%, e.g. about 0.3% in a dentifrice or preferably about 0.01-0.3% by weight, most preferably about 0.03-0.1% in a mouthwash or liquid dentifrice.
- the antibacterial agent is substantially water-insoluble, meaning that its solubility is less than about 1% by weight in water at 25° C. and even may be less than about 0.1%.
- the preferred halogenated diphenyl ether is triclosan.
- the preferred phenolic compounds are phenol, thymol, eugenol, and 2,2-methylene bis(4-chloro-6-bromophenol).
- Triclosan is disclosed in aformentioned U.S. Pat. No. 4,022,880 as an antibacterial agent in combination with an anticalculus agent which provides zinc ions and in German Patent Disclosure 3,532,860 in combination with a copper compound.
- European Patent Disclosure 0278,744 it is disclosed in combination with a tooth desensitizing agent containing a source of potassium ion.
- an antiplaque agent in a dentifrice formulated to contain a lamellar liquid crystal surfactant phase having a lamellar spacing of less than 6.0 nm and which may optionally contain a zinc salt in published European Patent Application 0161898 of Lane et al and in a dentifrice containing zinc citrate trihydrate in published European Patent Application 0161899 to Saxton et al.
- antibacterial-enhancing agent which enhances delivery of the antibacterial agent to, and retention thereof on, oral surfaces is described as distinct from poly(vinyl phosphonic acid) (PVPA) of the formula ##STR2## which, although being an AEA, does not contain a retention enhancing group.
- PVPA poly(vinyl phosphonic acid)
- the presently claimed invention is directed to the presence of PVPA, an AEA, which, as indicated, does not contain a retention enhancing group but, nevertheless, enhances antibacterial inhibition of plaque and gingivitis.
- PVPA is employed in amounts effective to achieve antibacterial enhancement, typically within the range in the oral composition of about 0.005% to about 4%, preferably about 0.1% to about 3%, more preferably about 0.5% to about 2.5% by weight.
- PVPA employed herein, typically has an average molecular weight of about 1,000 to about 1,000,000. Molecular weight values given for such polyvinyl phosphonates are obtained from viscosity or light scattering measurements.
- Synthetic anionic polyvinyl phosphonates have been previously disclosed as anticalculus agents per se in, U.S. Pat. No. 3,429,963 to Shedlovsky. However, that patent does not disclose use of such polyvinyl phosphonate agent for enhancing antibacterial activity.
- PVPA contains phosphonic groups which enhance delivery of antibacterial agent to the teeth and soft gum tissues. Although it does not contain a group which enhances retention of the antibacterial agent on the teeth and soft gum tissue, it is highly effective in retarding plaque and gingivitis.
- the phosphonic delivery-enhancing group attaches or substantively, adhesively, cohesively or otherwise bonds the PVPA (carrying the antibacterial agent) to oral (e.g. tooth and gum) surfaces, thereby "delivering" the antibacterial agent to such surfaces.
- the PVPA is an anionic polymer comprising a chain or backbone containing repeating vinyl units.
- the polyvinylphosphonate may be present in its water-soluble acid form, or salt (including acid salts) form. Salts include the alkali metal, preferably sodium or potassium, or ammonium water-soluble salts.
- the polymer has an average molecular weight of at least about 1,000, typically about 1,000 to about 1,000,000 and preferably about 6,000 to about 100,000 and most preferably about 6,000 to about 10,000, say about 6,000 to about 8,000. It may be polymerized from vinyl phosphonyl chloride by free radical polymerization in accordance with art recognized technique. The polyvinyl phosphonate is employed in amount of at least about 0.005% by weight to enhance antibacterial effect.
- compositions in approximate weight amounts of 0.05 to 4%, generally about 0.05 to 3%, preferably 0.05 to 2.5%, more preferably 0.1 to 2.5% by weight. Amounts of at least about 1% by weight are typically employed in dentifrice compositions, meaning oral compositions which generally contain a dental abrasive and used in conjunction with brushing of the teeth, e.g. tooth pastes including gels and creams, and powders. Amounts in excess of 4% by weight may be employed for thickening or gelling purposes.
- the orally acceptable vehicle is effective to enable the substantially water-insoluble noncationic antibacterial agent to dissolve in saliva in an effective antiplaque amount.
- Surface-active agent, flavoring oil or mixture thereof is effective for dissolving the antibacterial agent.
- an orally acceptable vehicle includes a water-phase with humectant present.
- a gel dentifrice typically containing about 5.30% by weight of a siliceous polishing agent
- water is typically present in amount of at least about 3% by weight, generally about 3.35%
- humectant preferably glycerine and/or sorbitol typically total about 6.5-75% or 80% by weight of the oral gel dentifrice composition.
- Reference hereto to sorbitol refers to the material typically as available commercially in 70% aqueous solutions.
- the gel dentifrices when the amount of antibacterial agent is about 0.25-0.35% by weight, do not require a further ingredient in the oral vehicle to solubilize the antibacterial agent, although the presence of such solubilizing agent is optional.
- solubilizing agent when the amount of antibacterial agent is below about 0.25% by weight, e.g. about 0.01 up to about 0.25% by weight, solubilizing agent therefore should be present in order to assure sufficient solubilization in saliva for antiplaque effectiveness.
- solubilizing agent when the amount of antibacterial agent is above about 0.35% by weight, e.g. about 0.35 to about 0.5% or more, say 5%, solubilizing agent therefore should be present since otherwise a substantial part of the antibacterial agent could remain insoluble.
- the oral composition is a dentifrice containing about 30-75% by weight of a dentally acceptable polishing agent
- the presence of such solubilizing agent is also optional.
- the oral vehicle desirably includes a non-toxic alcohol in addition to at least one of a surface-active agent and a flavoring oil, each of which assists in dissolving the antibacterial agent. Again the presence of the further solubilizing agent is optional.
- solubilizing agent When solubilizing agent is present in oral compositions of the instant invention, it is typically in amount of at least about 0.5% by weight being sufficient when the amount of substantially water-insoluble non-cationic antibacterial agent is low, say up to about 0.3% by weight. When higher amounts such as at least about 0.5% by weight of antibacterial agent are present and particularly when siliceous polishing agent is also present in amount of about 5.30% by weight, it is desirable that at least about 5% by weight, typically up to about 20% or more by weight, of the solubilizing agent be present. It is noted that there may be a tendency for the dentifrice to separate into liquid and solid portions when more than about 5% by weight of the solubilizing agent is present.
- the agent which is or may be present to assist solubilization of the antibacterial agent in saliva may be incorporated in the water-humectant vehicle.
- solubilizing agents include humectant polyols such as propylene glycol, dipropylene glycol and hexylene glycol, cellosolves such as methyl cellosolve and ethyl cellosolve, vegetable oils and waxes containing at least about 12 carbons in a straight chain such as olive oil, castor oil and petrolatum and esters such as amyl acetate, ethyl acetate and benzyl benzoate.
- humectant polyols such as propylene glycol, dipropylene glycol and hexylene glycol
- cellosolves such as methyl cellosolve and ethyl cellosolve
- vegetable oils and waxes containing at least about 12 carbons in a straight chain such as olive oil, castor oil and petrolatum and esters such
- polyethylene glycol 600 when present with triclosan in a weight ratio of 25 triclosan:1 PEG 600 reduces the antibacterial activity of triclosan by a factor of about 16 from that prevailing in the absence of the polyethylene glycol.
- oral compositions may be substantially gel in character, such as a gel dentifrice.
- Such gel oral preparations may contain siliceous dentally polishing material.
- Preferred polishing materials include silica gel or colloidal silica and complex amorphous alkali metal aluminosilicate.
- a polishing agent of colloidal silica such as those sold under the trademark SYLOID as Syloid 72 and Syloid 74 or under the trademark SANTOCEL as Santocel 100 or alkali metal aluminosilicate complexes (that is, silica containing alumina combined in its matrix) are particularly useful, since they are consistent with gel-like texture and have refractive indices close to the refractive indices of gelling agent-liquid (including water and/or humectant) systems commonly used in dentifrices).
- the polishing material is generally present in the oral composition dentifrices such as toothpaste or gel compositions in weight concentrations of about 5% to about 30%.
- an orally acceptable vehicle including a water-phase with humectant which is preferably glycerine and/or sorbitol is present, wherein water is present typically in amount of about 15-35% or 40% by weight and glycerine and/or sorbitol typically total about 20-75% by weight of the oral preparation dentifrice, more typically about 25-60%.
- humectant which is preferably glycerine and/or sorbitol
- the oral dentifrice composition may be substantially pasty in character, such as a toothpaste (dental cream), although when siliceous polishing agent is employed (which is not generally the case, since such material is typically not employed in amount above about 30% by weight) it can be gel in character.
- the vehicle of the oral composition dentifrice contains dentally acceptable polishing material, examples of which polishing materials are water-insoluble sodium metaphosphate, potassium metaphosphate, tricalcium phosphate, dihydrated dicalcium phosphate, anhydrous dicalcium phosphate, calcium carbonate, aluminum silicate, hydrated alumina, silica, bentonite, and mixtures thereof with each other or with hard polishing materials such as calcined alumina and zirconium silicate, material including the particulate thermosetting resins described in U.S. Pat. No. 3,070,510 issued Dec. 15, 1962, such as melamine-phenolic and urea-formaldehydes, and cross-linked polyepoxides and polyesters.
- Preferred polishing materials include insoluble sodium metaphosphates, dicalcium phosphate and hydrated alumina.
- insoluble sodium metaphosphate may be formed in any suitable manner as illustrated by Thorpe's Dictionary of Applied Chemistry, Volume 9, 4th Edition, Pp. 510-511.
- Maddrell's salt and Kurrol's salt are further examples of suitable materials.
- These metaphosphate salts exhibit only a minute solubility in water, and therefore are commonly preferred to as insoluble metaphosphates (IMP).
- IMP insoluble metaphosphates
- the amount of soluble phosphate material which is believed to include a soluble sodium trimetaphosphate in the case of insoluble metaphosphate, may be reduced or eliminated by washing with water if desired.
- the insoluble alkali meal metaphosphate is typically employed in powder form of a particle size such that no more than 1% of the material is larger than 37 microns.
- Hydrated alumina is an example of a polishing material which is essentially nonionic in nature. Typically, it is small in particle size, i.e., at least about 85% of the particles are smaller than 20 microns and is such as that classified as gibbsite (alpha alumina trihydrate) and normally represented chemically as Al 2 O 3 .3H 2 O or Al(OH).
- the average particle size of gibbsite is generally about 6 to 9 microns.
- a typical grade has the following size distribution:
- the polishing material is generally present in the cream paste or gel compositions in weight contents of about 30% to about 75%.
- Toothpastes or dental cream dentifrices as well as gel dentifrices typically contain a natural or synthetic thickener or gelling agent in proportions of about 0.1 to about 10%, preferably about 0.5 to about 5%.
- a suitable thickener is synthetic colloidal magnesium alkali metal silicate complex clay available, for example, as Laponite (e.g. CP, SP 2002, D) marketed by Laporte Industries Limited. Laponite D analysis shows, approximately by weight, 58.00% SiO 2 , 25.40% MgO, 3.05% Na 2 O, 0.98% Li 2 O, and some water and trace metals. Its true specific gravity is 2.53 and it has an apparent bulk density (g./ml. at 8% moisture) of 1.0.
- thickeners or gelling agents or thickeners include Irish moss, iota-carrageenan, gum tragacanth, starch, polyvinylpyrrolidone, hydroxyethylpropyl cellulose, hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose (e.g. available as Natrosol), sodium carboxymethyl cellulose, and particularly when siliceous polishing agent is present, colloidal silica such as those available as finely ground Syloid 244 or Sylodent 15.
- the vehicle particularly in a mouthwash, is typically a water-alcohol mixture.
- the weight ratio of water to alcohol is in the range of from about 1:1 to about 20:1, preferably about 3:1 to 10:1 and more preferably about 4:1 to about 6:1.
- the total amount of water-alcohol mixture in this type of preparation is typically in the range of from about 70 to about 99.9% by weight.
- the alcohol is a non-toxic alcohol such as ethanol or isopropanol.
- Humectant such as glycerine and sorbitol may be present in amount of about 10-30% by weight.
- Liquid dentifrices typically contain about 50-85% of water, may contain about 0.5-20% by weight of non-toxic alcohol and may also contain about 10-40% by weight of humectant such as glycerine and/or sorbitol.
- Reference here to sorbitol refers to the material typically as available commercially in 70% aqueous solutions.
- Ethanol is the preferred non-toxic alcohol. The alcohol is believed to assist in dissolving the water-insoluble non-cationic antibacterial agent as, it is believed also does flavoring oil.
- noncationic antibacterial agent is substantially water-insoluble.
- non-toxic alcohol is often present in addition to at least one of organic surface-active agent and flavoring oil or non-toxic alcohol to aid dissolving the antibacterial agent to assist it to reach soft oral tissue at or near the gums as well as tooth surfaces.
- Organic surface-active agents and/or flavoring oils may also assist dissolving the antibacterial agents as optional ingredients in oral dentifrice compositions.
- Organic surface-active agents are also used in the compositions of the present invention to achieve increased prophylactic action as well as to assist in achieving thorough and complete dispersion of the antiplaque antibacterial agent throughout the oral cavity and render the instant compositions more cosmetically acceptable.
- the organic surface-active material is preferably anionic, nonionic or ampholytic in nature, and it is preferred to employ as the surface-active agent a detersive material which imparts to the composition detersive and foaming properties.
- anionic surfactants are water-soluble salts of higher fatty acid monoglyceride monosulfates, such as the sodium salt of the monosulfated monoglyceride of hydrogenated coconut oil fatty acids, higher alkyl sulfates such as sodium lauryl sulfate, alkyl aryl sulfonates such as sodium dodecyl benzene sulfonate, higher alkyl sulfoacetates, higher fatty acid esters of 1,2-dihydroxy propane sulfonate, alkyl alkyl taurines, and the substantially saturated higher aliphatic acyl amides of lower aliphatic amino carboxylic acid compounds, such as those having 12 to 16 carbons in the fatty acid, alkyl or acyl radicals, and the like.
- higher alkyl sulfates such as sodium lauryl sulfate, alkyl aryl sulfonates such as sodium dodecyl benzene s
- amides are N-methyl-N-cococyl taurate, N-methyl-N-oleoyl taurate, N-methyl-N-palmitoyl-taurate, N-lauroyl sarcosinate, and the sodium, potassium, and ethanolamine salts of N-lauroyl, N-myristoyl, or N-palmitoyl sarcosine which should be substantially free from soap or similar higher fatty acid material.
- the taurine compounds particularly assist solution.
- water-soluble nonionic surfactants are condensation products of ethylene oxide with various reactive hydrogen containing compounds reactive therewith having hydrophobic chains (e.g. aliphatic chains of about 12 to 20 carbon atoms), which condensation products (“ethoxamers”) contain hydrophilic polyoxyethylene moieties, such as condensation products of poly (ethylene oxide) with fatty acids, fatty alcohols, fatty amides, polyhydric alcohols (e.g. sorbitan monostearate) and polypropyleneoxide (e.. Pluronic materials).
- Surface active agent including mixtures thereof, is typically present in amount of about 0.4-5% by weight, preferably about 0.4-0.6% for anionic agents and about 1-2.5%.
- the natural or synthetic thickener or gelling agent as described is typically present in proportions of about 0.1 to about I0%, preferably about 0.5 to about 5%.
- Liquid dentifrices may contain a polishing agent.
- a polishing agent such as hydrated alumina, dicalcium phosphate dihydrate, calcium pyrophosphate, insoluble sodium metaphosphate, anhydrous dicalcium phosphate, calcium carbonate, magnesium carbonate, magnesium oxide, silica, mixtures thereof, and the like is employed.
- flavoring or sweetening material may also be employed.
- suitable flavoring constituents are flavoring oils, e.g. oil of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon, and orange, and methyl salicylate.
- suitable sweetening agents include sucrose, lactose, maltose, xylitol, sodium cyclamate, perillartine, AMP (aspartyl phenyl alanine, methyl ester), saccharine and the like.
- flavor and sweetening agents may each or together comprise from about 0.1% to 5% or more of the preparation.
- flavoring oil is believed to aid the dissolving of the antibacterial agent, together with or even in the absence of surface-active agent.
- an aqueous, humectant vehicle is normally solubilized in surfactant micelles in the mobile phase (that is, not including gelling agent and polishing agent, if present in a dentifrice formula).
- the mobile phase solution of dentifrice during use can become diluted with saliva which causes triclosan to resolubilize.
- a special solubilizing material, for triclosan when the amount of triclosan is about 0.25% -0.35% by weight and PVPA and vehicle is present.
- Triclosan and flavor and/or surfactant are in the anterior of the micelle while PVPA is in the exterior.
- sufficient triclosan is present to exert an excellent antiplaque effect on the soft tissues at the gum line. Similar remarks apply to other water-insoluble noncationic antibacterial agents herein described.
- the oral composition may also contain linear molecularly dehydrated polyphosphate salts employed in the form of their wholly partially neutralized water soluble alkali metal e.g. potassium and preferably sodium) or ammonium salts, and mixtures thereof.
- linear molecularly dehydrated polyphosphate salts employed in the form of their wholly partially neutralized water soluble alkali metal e.g. potassium and preferably sodium) or ammonium salts, and mixtures thereof.
- Representative examples include sodium hexametaphosphate, sodium tripolyphosphate, disodium diacid, trisodium monoacid and tetrasodium pyrophosphates, the corresponding potassium salts and the like, including mixtures thereof. When present, they are preferably employed in the oral compositions in approximate weight amounts of 0.1% to 3% typically 1 to 2.5% more typically 1.5 to 2%.
- Oral compositions containing polyphosphate and PVPA are described in commonly assigned U.S. Pat. No. 5,094,844, issued Mar. 10, 1992.
- a ratio of PVPA to polyphosphate ion of about 1:6 to about 2.7:1 can be particularly desirable.
- Various other materials may be incorporated in the oral preparations of this invention such as whitening agents, preservatives, silicones, chlorophyll compounds and/or ammoniated material such as urea, diammonium phosphate, and mixtures thereof.
- Additional anticalculus agent such as azacycloheptane-2,2 diphosphonate, may also be employed, typically in amount of about 0.1-5% by weight.
- These adjuvants, where present, are incorporated in the preparations in amounts which do not substantially adversely affect the properties and characteristics desired. Significant amounts of zinc, magnesium and other metal salts and materials, which are generally soluble and which would complex with active components of the instant invention are to be avoided.
- the oral composition may also contain a source of fluoride ions or fluorine-providing component as anticaries agent in amount sufficient to supply about 25 ppm. to 5,000 ppm. of fluoride ions. This component also inhibits enzymatic degration of polyphosphate, if present.
- These compounds may be slightly soluble in water or more preferably fully water-soluble. They are characterized by ability to release fluoride ions in water and by substantial freedom from undesired reaction with other compounds of the oral preparation.
- inorganic fluoride salts such as soluble alkali metal fluorides, for example, sodium fluoride, potassium fluoride and ammonium fluoride, calcium fluoride, a copper fluoride such as cuprous fluoride, zinc fluoride, barium fluoride, sodium fluorosilicate, ammonium fluorosilicate, sodium fluorozirconate, ammonium fluorozirconate, sodium monofluorophosphate, aluminum mono- and di-fluorophosphate, and fluorinated sodium calcium pyrophosphate.
- Alkali metal and tin fluorides such as sodium and stannous fluorides, sodium monofluorophosphate (MFP) and mixtures thereof, are preferred.
- the amount of fluorine-providing compound is dependent to some extent upon the type of compound, its solubility, and the type of oral preparation, but it must be a non-toxic amount, generally about 0.0005 to about 3.0% in the preparation.
- a dentifrice preparation e.g. dental gel an amount of such compound which releases up to about 5,000 ppm of F ion by weight of the preparation is considered satisfactory.
- Any suitable minimum amount of such compound may be used, but it is preferable to employ sufficient compound to release about 300 to 2,000 ppm, more preferably about 800 to about 1,500 ppm of fluoride ion.
- this component is present in an amount up to about 2% by weight, based on the weight of the preparation, and preferably in the range of about 0.05% to 1%.
- the compound may be present in an amount of about 0.1-3%, more typically about 0.76%.
- a dentifrice gel will usually e in a collapsible tube typically aluminum, lined lead or plastic, or the squeeze, pump or pressurized dispenser for metering out the contents, having a label describing it, in substance, as a dentifrice gel or the like.
- an oral composition of the present invention is preferably applied regularly to dental enamel and soft oral tissues, particularly at or near the gum line, such as every day or every second or third day or preferably from 1 to 3 times daily, at a pH of about 4.5 to about 9 or 10, generally abut 5.5 to about 8, preferably about 6 to 8 and most preferably about 6.5 to about 7.5, for at least 2 weeks up to 8 weeks or more up to lifetime. Even at such pH below 5 enamel is not decalcified or otherwise damaged.
- the pH can be controlled with acid (e.g. citric acid or benzoic acid) or base (e,g, sodium hydroxide) or buffered as with sodium citrate, benzoate, carbonate or bicarbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, etc.).
- compositions of this invention can be incorporated in lozenges, or in chewing gum or other products, e.g. by stirring into a warm gum base or coating the outer surface of a gum base, illustrative of which may be mentioned gelating, rubber latex, vinylite resins, etc., desirably with conventional plasticizers or softeners, sugar or other sweeteners or carbohydrates such as glucose, sorbitol and the like.
- a clinical test is conducted with ten persons, aged 24-40 years (mean 29.5), all being free from signs of destructive periodontal disease and who have not been on systemic antibiotic therapy during the 6 months preceding this study.
- the participants are exposed to professional plaque control measures and are given repeated instructions in self performed plaque control measures.
- each participant receives a full professional tooth cleaning and then abstains from all mechanical tooth cleaning efforts during the course of the next four days. They rinse, however, twice daily, for one minute each time with 10 ml of the test solution.
- the ten subjects are clinically examined. Immediately following the examinations, they are given professional tooth cleaning and again follow the self performed plaque control measures for 10 days. The participants are then given professional tooth cleaning after which an additional four day test period is initiated. Thus, each person is his own control.
- Dentifrices are prepared having the following formulas:
- solubilizing agents particularly dipropylene glycol, hexylene glycol, methyl cellosolve, ethyl cellosolve, olive oil, castor oil, petrolatum, amyl acetate, ethyl acetate, glycerol tristerate and benzyl benzoate
- propylene glycol triclosan is effectively delivered to soft oral tissues.
- propylene glycol or other solubilizing agents are omitted from the toothpaste containing 0.3% triclosan.
- triclosan can be effectively replaced with each of phenol, 2,2'-methylene bis (4-chloro-6-bromophenol), eugenol and thymol.
- the concentration of the above mobile phases are 75% of finished dentifrice level to reflect 25% level of polishing agent to make a complete dentifrice.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
An oral composition such as a dentifrice or mouth-wash, comprises an effective antiplaque amount of a substantially water-insoluble noncationic antibacterial agents, such as 2,4,4-trichloro-2'-hydroxy-diphenyl ether (Triclosan) and polyvinyl phosphonate antibacterial-enhancing agent which enhances the delivery of said antibacterial agent to oral surfaces.
Description
This application is a continuation-in-part of application Ser. No. 07/754,887 filed Sep. 6, 1991, now U.S. Pat. No. 5,192,530, issued Mar. 9, 1993, which is a continuation of Ser. No. 07/398,606 filed Aug. 25, 1989, now abandoned; a continuation-in-part of application Ser. No. 07/655,571, filed Feb. 14, 1991, now U.S. Pat. No. 5,178,851, issued Jan. 12, 1993, which is a continuation of application Ser. No. 07/398,566 filed Aug. 28, 1989, now U.S. Pat. No. 5,032,386, issued Jul. 16, 1991; a continuation-in-part of application Ser. No. 07/758,345, filed Sep. 9, 1991, now U.S. Pat. No. 5,192,531, issued Mar. 9, 1993, which is a continuation of Ser. No. 07/399,669, filed Aug. 25, 1989, now abandoned; a continuation-in-part of application Ser. No. 07/398,592, filed Aug. 28, 1998, now U.S. Pat. No. 5,188,821, issued Feb. 23, 1993, and a continuation-in-part of application Ser. No. 07/657,885, filed Feb. 19, 1991, now U.S. Pat. No. 5,180,578, issue Jan. 19, 1993, which is a continuation of application Ser. No. 07/398,605, filed Aug. 25, 1989, now abandoned.
This invention relates to an antibacterial antiplaque oral compositions such as dentifrices and mouthwashes. More particularly, it relates to oral compositions containing a substantially water-insoluble noncationic antibacterial agent effective to inhibit plaque.
Dental plaque is a soft deposit which forms on teeth as opposed to calculus which is a hard calcified deposit on teeth. Unlike calculus, plaque may form on any part of the tooth surface, particularly including at the gingival margin. Hence, besides being unsightly, it is implicated in the occurrence of gingivitis.
Accordingly, it is highly desirable to include antimicrobial agents which have been known to reduce plaque in oral compositions. Frequently, cationic antibacterial agents have been suggested. Moreover, in U.S. Pat. No. 4,022,880 to Vinson et al, a compound providing zinc ions as an anticalculus agent is admixed with an antibacterial agent effective to retard the growth of plaque bacteria. A wide variety of antibacterial agents are described with the zinc compounds including cationic materials such as guanides and quaternary ammonium compounds as well as non-cationic compounds such as halogenated salicylanilides and halogenated hydroxydiphenyl ethers. The noncationic antibacterial antiplaque halogenated hydroxydiphenyl ether, triclosan, has also been described in combination with zinc citrate trihydrate in European Patent 0161,899 to Saxton et al. Triclosan is also disclosed in European Patent Publication 0271,332 to Davis as a toothpaste component containing a solubilizing agent such as propylene glycol and in PCT Publication WD 92/00721 to Read in combination with azacycloalkane diphosphonates.
The cationic antibacterial materials such as chlorhexidine, benzthonium chloride and cetyl pyridinium chloride have been the subject of greatest investigation as antibacterial antiplaque agents. However, they are generally not effective when used with anionic materials. Noncationic antibacterial materials, on the other hand, can be compatible with anionic components in an oral composition.
However, oral compositions typically are mixtures of numerous components and even such typically neutral materials as humectants can affect performance of such compositions.
Moreover, even noncationic antibacterial agents may have limited antiplaque effectiveness with commonly used materials such as polyphosphate anticalculus agents which are disclosed together in British Patent Publication 22 00551 of Gaffar et al and in EP 0251591 of Jackson et al.
It is an advantage of this invention that an oral composition is provided comprising a substantially water. insoluble noncationic antibacterial agent wherein polyvinyl phosphonate (PVPA) enhances the antibacterial effect of the antibacterial agent to inhibit plaque formation, wherein the oral composition contains an orally acceptable liquid vehicle effective to enable said antibacterial agent to dissolve in saliva in effective antiplaque amount.
It is a further advantage of this invention that an antiplaque oral composition is provided which is effective to reduce the occurrence of gingivitis.
Additional advantages of this invention will be apparent from consideration of the following specification.
In accordance with certain of its aspects, this invention relates to an oral composition comprising an effective antiplaque amount of a substantially water insoluble noncationic antibacterial agent, at least about 0.005% by weight of polyvinyl phosphonate having recurring groups ##STR1## and average molecular weight of at least about 1,000 and wherein M and M1 are hydrogen, alkali metal or ammonium and wherein M and M1 are the same or different and an orally acceptable vehicle comprising at least one of a surface-active agent or a flavoring oil effective to enable said antibacterial agent to dissolve in saliva in effective antiplaque amount.
Typical examples of water insoluble noncationic antibacterial agents which are particularly desirable from considerations of antiplaque effectiveness, safety and formulation are:
2,4,4'-trichloro-2'-hydroxy-diphenyl ether (Triclosan)
2,2'-dihydroxy-5,5'-dibromo-diphenyl ether
4',5'-dibromosalicylanilide
3,4,5,'-trichlorosalcylanilide
3,4,5-tribromosalicylanilide
2,3,3',5-tetrachlorosalicylanilide
3,5-dibromo-3'-trifluoromethyl salicylanilide
5-n-octanoyl-3'-trifluoromethyl salicylanilide
3,5-dibromo-4'-trifluoromethyl salicylanilide
3,5-dibromo-3'-trifluoromethyl salicylanilide (Flurophene)
Methyl-p-Hydroxybenzoic Ester
Ethyl-p-Hydroxybenzoic Ester
Propyl-p-Hydroxybenzoic Ester
Butyl-p-Hydroxybenzoic Ester
3,4,4'-trichlorocarbanilide
2-trifluormethyl-4,4'-dichlorcarbanilide
3,3,4'-trichlorocarbanilide
Phenolic Compounds (including phenol and its homoglogs, mono- and poly-alkyl and aromatic halo (e.g., Cl, Br, I)-phenols, resorcinol and catechol and their derivatives and bisphenolic compounds). Such compounds include inter alia:
______________________________________ Phenol and its Homlogs Phenol 2-Methyl Phenol 3-Methyl Phenol 4-Methyl Phenol 4-Ethyl Phenol 2,4-Dimethyl Phenol 2,5-Dimethyl Phenol 3,4-Dimethyl Phenol 2,6-Dimethyl Phenol 4-n-Propyl Phenol 4-n-Butyl Phenol 4-n-Amyl Phenol 4-tert-Amyl Phenol 4-n-Hexyl Phenol 4-n-Heptyl Phenol 2-Methoxy-(2-Propenyl)-Phenol (Eugenol) 2-Isopropyl-5-Methyl-Phenol (Thymol) Mono- and Poly-Alkyl and Aromatic Halophenols Methyl p-Chlorophenol Ethyl p-Chlorophenol n-Propyl p-Chlorophenol n-Butyl p-Chlorophenol n-Amyl p-Chlorophenol n-Hexyl p-Chlorophenol Cyclohexyl p-Chlorophenol n-Heptyl p Chlorophenol n-Octyl p-Chlorophenol O-Chlorophenol Methyl o-Chlorophenol Ethyl o-Chlorophenol n-Propyl o-Chlorophenol n-Butyl o-Chlorophenol n-Amyl o-Chlorophenol Tert-Amyl o-Chlorophenol n-Hexyl o-Chlorophenol n-Heptyl o-Chlorophenol p-Chlorophenol o-Benzyl p-Chlorophenol o-Benzyl-m-methyl p-Chlorophenol o-Benzyl-m-m-dimethyl p-Chlorophenol o-Phenylethyl p-Chlorophenol o-Phenylethyl-m-methyl p-Chlorophenol 3-Methyl p-Chlorophenol 3,5-Dimethyl p-Chlorophenol 6-Ethyl-3-methyl p-Chlorophenol 6-n-Propyl-3-methyl p-Chlorophenol 6-iso-Propyl-3-methyl p-Chlorophenol 2-Ethyl-3,5-dimethyl p-Chlorophenol 6-sec Butyl-3-methyl p-Chlorophenol 2-iso-Propyl-3-5-methyl p-Chlorophenol 6-Diethylmethyl-3-methyl p-Chlorophenol 6-iso-Propyl-2-ethyl-3-methyl p-Chlorophenol 2-sec amyl-3,5-dimethyl p-Chlorophenol 2-Diethylmethyl-3,5-dimethyl p-Chlorophenol 6-sec Octyl-3-methyl p-Chlorophenol p-Bromophenol Methyl p-Bromophenol Ethyl p-Bromophenol n-Propyl p-Bromophenol n-Butyl p-Bromophenol n-Amyl p-Bromophenol sec-Amyl p-Bromophenol n-Hexyl p-Bromophenol Cyclohexyl p-Bromophenol o-Bromophenol Tert-Amyl o-Bromophenol n-Hexyl o-Bromophenol n-Propyl-m,m-Dimethyl o-Bromophenol 2-Phenyl Phenol 4-chloro-2-methyl phenol 4-chloro-3-methyl phenol 4-chloro 3,5-dimethyl phenol 2,4-dichloro-3,5-dimethylphenol 3,4,5,6-terabromo-2-methylphenol 5-methyl-2-pentylphenol 4-isopropyl-3-methylphenol 5-chloro-2-hydroxydiphenylmethane Resorcinol and Its Derivatives Resorcinol Methyl Resorcinol Ethyl Resorcinol n-Propyl Resorcinol n-Butyl Resorcinol n-Amyl Resorcinol n-Hexyl Resorcinol n-Heptyl Resorcinol n-Octyl Resorcinol n-Nonyl Resorcinol Phenyl Resorcinol Benzyl Resorcinol Phenylethyl Resorcinol Phenylpropyl Resorcinol p-Chlorobenzyl Resorcinol 5-Chloro 2,4-Dihydroxydiphenyl Methane 4'-Chloro 2,4-Dihydroxydiphenyl Methane 5-Bromo 2,4-Dihydrocydiphenyl Methane 4'-Bromo 2,4-Dihydroxydiphenyl Methane Bisphenolic Compounds 2,2'-methylene bis (4-chlorophenol) 2,2'-methylene bis (3,4,6-trichlorophenol) (hexachlorophene) 2,2'-methylene bis (4-chloro-6-bromophenol) bis (2-hydroxy-3,5-dichlorophenyl) sulfide bis (2-hydroxy-5-chlorobenzyl) sulfide ______________________________________
The noncationic antibacterial agent is present in the composition of the present invention in an effective antiplaque amount, preferably about 0.01-5% by weight, more preferably about 0.25-0.5% or about 0.05 to less than 0.5% and most preferably about 0.25-0.35%, e.g. about 0.3% in a dentifrice or preferably about 0.01-0.3% by weight, most preferably about 0.03-0.1% in a mouthwash or liquid dentifrice. The antibacterial agent is substantially water-insoluble, meaning that its solubility is less than about 1% by weight in water at 25° C. and even may be less than about 0.1%.
The preferred halogenated diphenyl ether is triclosan. The preferred phenolic compounds are phenol, thymol, eugenol, and 2,2-methylene bis(4-chloro-6-bromophenol). Triclosan is disclosed in aformentioned U.S. Pat. No. 4,022,880 as an antibacterial agent in combination with an anticalculus agent which provides zinc ions and in German Patent Disclosure 3,532,860 in combination with a copper compound. In European Patent Disclosure 0278,744 it is disclosed in combination with a tooth desensitizing agent containing a source of potassium ion. It is also disclosed as an antiplaque agent in a dentifrice formulated to contain a lamellar liquid crystal surfactant phase having a lamellar spacing of less than 6.0 nm and which may optionally contain a zinc salt in published European Patent Application 0161898 of Lane et al and in a dentifrice containing zinc citrate trihydrate in published European Patent Application 0161899 to Saxton et al.
In the ancestor application of the present application, antibacterial-enhancing agent (AEA) which enhances delivery of the antibacterial agent to, and retention thereof on, oral surfaces is described as distinct from poly(vinyl phosphonic acid) (PVPA) of the formula ##STR2## which, although being an AEA, does not contain a retention enhancing group. The presently claimed invention is directed to the presence of PVPA, an AEA, which, as indicated, does not contain a retention enhancing group but, nevertheless, enhances antibacterial inhibition of plaque and gingivitis. PVPA is employed in amounts effective to achieve antibacterial enhancement, typically within the range in the oral composition of about 0.005% to about 4%, preferably about 0.1% to about 3%, more preferably about 0.5% to about 2.5% by weight.
PVPA, employed herein, typically has an average molecular weight of about 1,000 to about 1,000,000. Molecular weight values given for such polyvinyl phosphonates are obtained from viscosity or light scattering measurements.
Synthetic anionic polyvinyl phosphonates have been previously disclosed as anticalculus agents per se in, U.S. Pat. No. 3,429,963 to Shedlovsky. However, that patent does not disclose use of such polyvinyl phosphonate agent for enhancing antibacterial activity.
PVPA contains phosphonic groups which enhance delivery of antibacterial agent to the teeth and soft gum tissues. Although it does not contain a group which enhances retention of the antibacterial agent on the teeth and soft gum tissue, it is highly effective in retarding plaque and gingivitis.
As employed herein, the phosphonic delivery-enhancing group attaches or substantively, adhesively, cohesively or otherwise bonds the PVPA (carrying the antibacterial agent) to oral (e.g. tooth and gum) surfaces, thereby "delivering" the antibacterial agent to such surfaces.
The PVPA is an anionic polymer comprising a chain or backbone containing repeating vinyl units.
The polyvinylphosphonate may be present in its water-soluble acid form, or salt (including acid salts) form. Salts include the alkali metal, preferably sodium or potassium, or ammonium water-soluble salts. The polymer has an average molecular weight of at least about 1,000, typically about 1,000 to about 1,000,000 and preferably about 6,000 to about 100,000 and most preferably about 6,000 to about 10,000, say about 6,000 to about 8,000. It may be polymerized from vinyl phosphonyl chloride by free radical polymerization in accordance with art recognized technique. The polyvinyl phosphonate is employed in amount of at least about 0.005% by weight to enhance antibacterial effect. It is generally employed in the compositions in approximate weight amounts of 0.05 to 4%, generally about 0.05 to 3%, preferably 0.05 to 2.5%, more preferably 0.1 to 2.5% by weight. Amounts of at least about 1% by weight are typically employed in dentifrice compositions, meaning oral compositions which generally contain a dental abrasive and used in conjunction with brushing of the teeth, e.g. tooth pastes including gels and creams, and powders. Amounts in excess of 4% by weight may be employed for thickening or gelling purposes.
In accordance with the present invention, the orally acceptable vehicle is effective to enable the substantially water-insoluble noncationic antibacterial agent to dissolve in saliva in an effective antiplaque amount. Surface-active agent, flavoring oil or mixture thereof is effective for dissolving the antibacterial agent.
In the oral preparation, an orally acceptable vehicle includes a water-phase with humectant present. In a gel dentifrice, typically containing about 5.30% by weight of a siliceous polishing agent, water is typically present in amount of at least about 3% by weight, generally about 3.35%, and humectant, preferably glycerine and/or sorbitol typically total about 6.5-75% or 80% by weight of the oral gel dentifrice composition. Reference hereto to sorbitol refers to the material typically as available commercially in 70% aqueous solutions.
The gel dentifrices, when the amount of antibacterial agent is about 0.25-0.35% by weight, do not require a further ingredient in the oral vehicle to solubilize the antibacterial agent, although the presence of such solubilizing agent is optional. When the amount of antibacterial agent is below about 0.25% by weight, e.g. about 0.01 up to about 0.25% by weight, solubilizing agent therefore should be present in order to assure sufficient solubilization in saliva for antiplaque effectiveness. When the amount of antibacterial agent is above about 0.35% by weight, e.g. about 0.35 to about 0.5% or more, say 5%, solubilizing agent therefore should be present since otherwise a substantial part of the antibacterial agent could remain insoluble.
When the oral composition is a dentifrice containing about 30-75% by weight of a dentally acceptable polishing agent, the presence of such solubilizing agent is also optional.
When the oral composition is a mouthwash or liquid dentifrice, the oral vehicle desirably includes a non-toxic alcohol in addition to at least one of a surface-active agent and a flavoring oil, each of which assists in dissolving the antibacterial agent. Again the presence of the further solubilizing agent is optional.
When solubilizing agent is present in oral compositions of the instant invention, it is typically in amount of at least about 0.5% by weight being sufficient when the amount of substantially water-insoluble non-cationic antibacterial agent is low, say up to about 0.3% by weight. When higher amounts such as at least about 0.5% by weight of antibacterial agent are present and particularly when siliceous polishing agent is also present in amount of about 5.30% by weight, it is desirable that at least about 5% by weight, typically up to about 20% or more by weight, of the solubilizing agent be present. It is noted that there may be a tendency for the dentifrice to separate into liquid and solid portions when more than about 5% by weight of the solubilizing agent is present.
The agent which is or may be present to assist solubilization of the antibacterial agent in saliva may be incorporated in the water-humectant vehicle. Such solubilizing agents include humectant polyols such as propylene glycol, dipropylene glycol and hexylene glycol, cellosolves such as methyl cellosolve and ethyl cellosolve, vegetable oils and waxes containing at least about 12 carbons in a straight chain such as olive oil, castor oil and petrolatum and esters such as amyl acetate, ethyl acetate and benzyl benzoate. As used herein, "propylene glycol" includes 1,2-propylene glycol and 1,3-propylene glycol. Significant amounts of polyethylene glycol particularly of molecular weight of 600 or more should be avoided since polyethylene glycol effectively inhibits the antibacterial activity of the noncationic antibacterial agent. For instance, polyethylene glycol (PEG) 600 when present with triclosan in a weight ratio of 25 triclosan:1 PEG 600 reduces the antibacterial activity of triclosan by a factor of about 16 from that prevailing in the absence of the polyethylene glycol.
In accordance with aspects of this invention, oral compositions may be substantially gel in character, such as a gel dentifrice. Such gel oral preparations may contain siliceous dentally polishing material. Preferred polishing materials include silica gel or colloidal silica and complex amorphous alkali metal aluminosilicate.
When visually clear or opacified gels are employed, a polishing agent of colloidal silica, such as those sold under the trademark SYLOID as Syloid 72 and Syloid 74 or under the trademark SANTOCEL as Santocel 100 or alkali metal aluminosilicate complexes (that is, silica containing alumina combined in its matrix) are particularly useful, since they are consistent with gel-like texture and have refractive indices close to the refractive indices of gelling agent-liquid (including water and/or humectant) systems commonly used in dentifrices).
The polishing material is generally present in the oral composition dentifrices such as toothpaste or gel compositions in weight concentrations of about 5% to about 30%.
In the aspect of this invention wherein the oral preparation is a dentifrice, an orally acceptable vehicle including a water-phase with humectant which is preferably glycerine and/or sorbitol is present, wherein water is present typically in amount of about 15-35% or 40% by weight and glycerine and/or sorbitol typically total about 20-75% by weight of the oral preparation dentifrice, more typically about 25-60%. Reference hereto to sorbitol again refers to the material typically as available commercially in 70% aqueous solutions.
In this invention, the oral dentifrice composition may be substantially pasty in character, such as a toothpaste (dental cream), although when siliceous polishing agent is employed (which is not generally the case, since such material is typically not employed in amount above about 30% by weight) it can be gel in character. The vehicle of the oral composition dentifrice contains dentally acceptable polishing material, examples of which polishing materials are water-insoluble sodium metaphosphate, potassium metaphosphate, tricalcium phosphate, dihydrated dicalcium phosphate, anhydrous dicalcium phosphate, calcium carbonate, aluminum silicate, hydrated alumina, silica, bentonite, and mixtures thereof with each other or with hard polishing materials such as calcined alumina and zirconium silicate, material including the particulate thermosetting resins described in U.S. Pat. No. 3,070,510 issued Dec. 15, 1962, such as melamine-phenolic and urea-formaldehydes, and cross-linked polyepoxides and polyesters. Preferred polishing materials include insoluble sodium metaphosphates, dicalcium phosphate and hydrated alumina.
Many of the so-called "water-insoluble" polishing materials are anionic in character and also include small amounts of soluble material. Thus, insoluble sodium metaphosphate may be formed in any suitable manner as illustrated by Thorpe's Dictionary of Applied Chemistry, Volume 9, 4th Edition, Pp. 510-511. The forms of insoluble sodium metaphosphate known as Maddrell's salt and Kurrol's salt are further examples of suitable materials. These metaphosphate salts exhibit only a minute solubility in water, and therefore are commonly preferred to as insoluble metaphosphates (IMP). There is present therein a minor amount of soluble phosphate material as impurities, usually a few percent such as up to 4% by weight. The amount of soluble phosphate material, which is believed to include a soluble sodium trimetaphosphate in the case of insoluble metaphosphate, may be reduced or eliminated by washing with water if desired. The insoluble alkali meal metaphosphate is typically employed in powder form of a particle size such that no more than 1% of the material is larger than 37 microns.
Hydrated alumina is an example of a polishing material which is essentially nonionic in nature. Typically, it is small in particle size, i.e., at least about 85% of the particles are smaller than 20 microns and is such as that classified as gibbsite (alpha alumina trihydrate) and normally represented chemically as Al2 O3.3H2 O or Al(OH).
The average particle size of gibbsite is generally about 6 to 9 microns. A typical grade has the following size distribution:
______________________________________
Micron
Percent
______________________________________
<30 94-99
<20 85-93
<10 56-67
<5 28-40
______________________________________
The polishing material is generally present in the cream paste or gel compositions in weight contents of about 30% to about 75%.
Toothpastes or dental cream dentifrices as well as gel dentifrices typically contain a natural or synthetic thickener or gelling agent in proportions of about 0.1 to about 10%, preferably about 0.5 to about 5%. A suitable thickener is synthetic colloidal magnesium alkali metal silicate complex clay available, for example, as Laponite (e.g. CP, SP 2002, D) marketed by Laporte Industries Limited. Laponite D analysis shows, approximately by weight, 58.00% SiO2, 25.40% MgO, 3.05% Na2 O, 0.98% Li2 O, and some water and trace metals. Its true specific gravity is 2.53 and it has an apparent bulk density (g./ml. at 8% moisture) of 1.0.
Other suitable thickeners or gelling agents or thickeners include Irish moss, iota-carrageenan, gum tragacanth, starch, polyvinylpyrrolidone, hydroxyethylpropyl cellulose, hydroxybutyl methyl cellulose, hydroxypropyl methyl cellulose, hydroxyethyl cellulose (e.g. available as Natrosol), sodium carboxymethyl cellulose, and particularly when siliceous polishing agent is present, colloidal silica such as those available as finely ground Syloid 244 or Sylodent 15.
In the aspect of the present invention wherein the oral composition is a mouthwash or liquid dentifrice, that is, it is substantially liquid in character, the vehicle, particularly in a mouthwash, is typically a water-alcohol mixture. Generally, the weight ratio of water to alcohol is in the range of from about 1:1 to about 20:1, preferably about 3:1 to 10:1 and more preferably about 4:1 to about 6:1. The total amount of water-alcohol mixture in this type of preparation is typically in the range of from about 70 to about 99.9% by weight. The alcohol is a non-toxic alcohol such as ethanol or isopropanol. Humectant such as glycerine and sorbitol may be present in amount of about 10-30% by weight. Liquid dentifrices typically contain about 50-85% of water, may contain about 0.5-20% by weight of non-toxic alcohol and may also contain about 10-40% by weight of humectant such as glycerine and/or sorbitol. Reference here to sorbitol refers to the material typically as available commercially in 70% aqueous solutions. Ethanol is the preferred non-toxic alcohol. The alcohol is believed to assist in dissolving the water-insoluble non-cationic antibacterial agent as, it is believed also does flavoring oil.
As indicated, the noncationic antibacterial agent is substantially water-insoluble. However, in a mouthwash or liquid dentifrice of the present invention non-toxic alcohol is often present in addition to at least one of organic surface-active agent and flavoring oil or non-toxic alcohol to aid dissolving the antibacterial agent to assist it to reach soft oral tissue at or near the gums as well as tooth surfaces. Organic surface-active agents and/or flavoring oils may also assist dissolving the antibacterial agents as optional ingredients in oral dentifrice compositions.
Organic surface-active agents are also used in the compositions of the present invention to achieve increased prophylactic action as well as to assist in achieving thorough and complete dispersion of the antiplaque antibacterial agent throughout the oral cavity and render the instant compositions more cosmetically acceptable. The organic surface-active material is preferably anionic, nonionic or ampholytic in nature, and it is preferred to employ as the surface-active agent a detersive material which imparts to the composition detersive and foaming properties. Suitable examples of anionic surfactants are water-soluble salts of higher fatty acid monoglyceride monosulfates, such as the sodium salt of the monosulfated monoglyceride of hydrogenated coconut oil fatty acids, higher alkyl sulfates such as sodium lauryl sulfate, alkyl aryl sulfonates such as sodium dodecyl benzene sulfonate, higher alkyl sulfoacetates, higher fatty acid esters of 1,2-dihydroxy propane sulfonate, alkyl alkyl taurines, and the substantially saturated higher aliphatic acyl amides of lower aliphatic amino carboxylic acid compounds, such as those having 12 to 16 carbons in the fatty acid, alkyl or acyl radicals, and the like. Examples of the last mentioned amides are N-methyl-N-cococyl taurate, N-methyl-N-oleoyl taurate, N-methyl-N-palmitoyl-taurate, N-lauroyl sarcosinate, and the sodium, potassium, and ethanolamine salts of N-lauroyl, N-myristoyl, or N-palmitoyl sarcosine which should be substantially free from soap or similar higher fatty acid material. The taurine compounds particularly assist solution. The use of these sarcosinate compounds in the oral compositions of the present invention can be particularly advantageous since these materials exhibit a prolonged and marked effect in the inhibition of acid formation in the oral cavity due to carbohydrate breakdown in addition to exerting some reduction in the solubility of tooth enamel in acid solutions. Examples of water-soluble nonionic surfactants are condensation products of ethylene oxide with various reactive hydrogen containing compounds reactive therewith having hydrophobic chains (e.g. aliphatic chains of about 12 to 20 carbon atoms), which condensation products ("ethoxamers") contain hydrophilic polyoxyethylene moieties, such as condensation products of poly (ethylene oxide) with fatty acids, fatty alcohols, fatty amides, polyhydric alcohols (e.g. sorbitan monostearate) and polypropyleneoxide (e.. Pluronic materials).
Surface active agent, including mixtures thereof, is typically present in amount of about 0.4-5% by weight, preferably about 0.4-0.6% for anionic agents and about 1-2.5%.
When the oral composition is a liquid dentifrice the natural or synthetic thickener or gelling agent as described is typically present in proportions of about 0.1 to about I0%, preferably about 0.5 to about 5%.
Liquid dentifrices may contain a polishing agent. For instance, as described in U.S. Pat. No. 3,506,757 to Salzmann, when about 0.3-2.0% by weight of a polysaccharide of high molecular weight in excess of 1,000,000 containing mannose, glucose, potassium glucuronate and acetyl moieties in the approximate ratio of 2:1:1:1, as suspending and thickening agent is employed in a liquid dentifrice, about 10-20% of a polishing material such as hydrated alumina, dicalcium phosphate dihydrate, calcium pyrophosphate, insoluble sodium metaphosphate, anhydrous dicalcium phosphate, calcium carbonate, magnesium carbonate, magnesium oxide, silica, mixtures thereof, and the like is employed.
Any suitable flavoring or sweetening material may also be employed. Examples of suitable flavoring constituents are flavoring oils, e.g. oil of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon, and orange, and methyl salicylate. Suitable sweetening agents include sucrose, lactose, maltose, xylitol, sodium cyclamate, perillartine, AMP (aspartyl phenyl alanine, methyl ester), saccharine and the like. Suitably, flavor and sweetening agents may each or together comprise from about 0.1% to 5% or more of the preparation. Moreover, like the surface-active agent, flavoring oil is believed to aid the dissolving of the antibacterial agent, together with or even in the absence of surface-active agent.
Without being bound to a theory whereby the advantages of this invention are achieved, it is believed that an aqueous, humectant vehicle is normally solubilized in surfactant micelles in the mobile phase (that is, not including gelling agent and polishing agent, if present in a dentifrice formula). The mobile phase solution of dentifrice during use can become diluted with saliva which causes triclosan to resolubilize. Thus, it is found that, even in the absence of a special solubilizing material, for triclosan, when the amount of triclosan is about 0.25% -0.35% by weight and PVPA and vehicle is present. Triclosan and flavor and/or surfactant are in the anterior of the micelle while PVPA is in the exterior. Thus, sufficient triclosan is present to exert an excellent antiplaque effect on the soft tissues at the gum line. Similar remarks apply to other water-insoluble noncationic antibacterial agents herein described.
The oral composition may also contain linear molecularly dehydrated polyphosphate salts employed in the form of their wholly partially neutralized water soluble alkali metal e.g. potassium and preferably sodium) or ammonium salts, and mixtures thereof. Representative examples include sodium hexametaphosphate, sodium tripolyphosphate, disodium diacid, trisodium monoacid and tetrasodium pyrophosphates, the corresponding potassium salts and the like, including mixtures thereof. When present, they are preferably employed in the oral compositions in approximate weight amounts of 0.1% to 3% typically 1 to 2.5% more typically 1.5 to 2%. Oral compositions containing polyphosphate and PVPA are described in commonly assigned U.S. Pat. No. 5,094,844, issued Mar. 10, 1992.
When polyphosphate is present, a ratio of PVPA to polyphosphate ion of about 1:6 to about 2.7:1 can be particularly desirable.
Various other materials may be incorporated in the oral preparations of this invention such as whitening agents, preservatives, silicones, chlorophyll compounds and/or ammoniated material such as urea, diammonium phosphate, and mixtures thereof. Additional anticalculus agent such as azacycloheptane-2,2 diphosphonate, may also be employed, typically in amount of about 0.1-5% by weight. These adjuvants, where present, are incorporated in the preparations in amounts which do not substantially adversely affect the properties and characteristics desired. Significant amounts of zinc, magnesium and other metal salts and materials, which are generally soluble and which would complex with active components of the instant invention are to be avoided.
The oral composition may also contain a source of fluoride ions or fluorine-providing component as anticaries agent in amount sufficient to supply about 25 ppm. to 5,000 ppm. of fluoride ions. This component also inhibits enzymatic degration of polyphosphate, if present. These compounds may be slightly soluble in water or more preferably fully water-soluble. They are characterized by ability to release fluoride ions in water and by substantial freedom from undesired reaction with other compounds of the oral preparation. Among these materials are inorganic fluoride salts, such as soluble alkali metal fluorides, for example, sodium fluoride, potassium fluoride and ammonium fluoride, calcium fluoride, a copper fluoride such as cuprous fluoride, zinc fluoride, barium fluoride, sodium fluorosilicate, ammonium fluorosilicate, sodium fluorozirconate, ammonium fluorozirconate, sodium monofluorophosphate, aluminum mono- and di-fluorophosphate, and fluorinated sodium calcium pyrophosphate. Alkali metal and tin fluorides, such as sodium and stannous fluorides, sodium monofluorophosphate (MFP) and mixtures thereof, are preferred.
The amount of fluorine-providing compound is dependent to some extent upon the type of compound, its solubility, and the type of oral preparation, but it must be a non-toxic amount, generally about 0.0005 to about 3.0% in the preparation. In a dentifrice preparation, e.g. dental gel an amount of such compound which releases up to about 5,000 ppm of F ion by weight of the preparation is considered satisfactory. Any suitable minimum amount of such compound may be used, but it is preferable to employ sufficient compound to release about 300 to 2,000 ppm, more preferably about 800 to about 1,500 ppm of fluoride ion.
Typically, in the cases of alkali metal fluorides, this component is present in an amount up to about 2% by weight, based on the weight of the preparation, and preferably in the range of about 0.05% to 1%. In the case of sodium monofluorophosphate, the compound may be present in an amount of about 0.1-3%, more typically about 0.76%.
It will be understood that, as is conventional, the oral preparations are to be sold or otherwise distributed in suitable labelled packages. Thus a dentifrice gel will usually e in a collapsible tube typically aluminum, lined lead or plastic, or the squeeze, pump or pressurized dispenser for metering out the contents, having a label describing it, in substance, as a dentifrice gel or the like.
In the preferred practice of this invention, an oral composition of the present invention is preferably applied regularly to dental enamel and soft oral tissues, particularly at or near the gum line, such as every day or every second or third day or preferably from 1 to 3 times daily, at a pH of about 4.5 to about 9 or 10, generally abut 5.5 to about 8, preferably about 6 to 8 and most preferably about 6.5 to about 7.5, for at least 2 weeks up to 8 weeks or more up to lifetime. Even at such pH below 5 enamel is not decalcified or otherwise damaged. The pH can be controlled with acid (e.g. citric acid or benzoic acid) or base (e,g, sodium hydroxide) or buffered as with sodium citrate, benzoate, carbonate or bicarbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, etc.).
The compositions of this invention can be incorporated in lozenges, or in chewing gum or other products, e.g. by stirring into a warm gum base or coating the outer surface of a gum base, illustrative of which may be mentioned gelating, rubber latex, vinylite resins, etc., desirably with conventional plasticizers or softeners, sugar or other sweeteners or carbohydrates such as glucose, sorbitol and the like.
The following examples are further illustrative of the effective compositions of the present invention, but it is understood that the invention is not limited thereto. All amounts and proportions referred to herein and in the appended claims are by weight, unless otherwise indicated.
The following mouthrinses are prepared:
______________________________________
Parts
D
A B C Triclosan
Ingredients Placebo PVPA Triclosan
& PVPA
______________________________________
Sorbitol (70%)
20 20 20 20
Glycerine 10 10 10 10
Propylene Glycol
7 7 7 7
Ethanol 10 10 10 10
Triclosan -- -- 0.06 0.06
PVPA -- 3.00 -- 3.00
Avg. M.W. 6000-
8000
Sodium Fluoride
0.05 0.05 0.05 0.05
Flavor 0.25 0.25 0.25 0.25
Water Q.S. Q.S. Q.S. Q.S.
to 100 to 100 to 100 to 100
Sodium Lauryl
0.25 0.25 0.25 0.25
Sulphate
______________________________________
A clinical test is conducted with ten persons, aged 24-40 years (mean 29.5), all being free from signs of destructive periodontal disease and who have not been on systemic antibiotic therapy during the 6 months preceding this study. During a preparatory period of two weeks the participants are exposed to professional plaque control measures and are given repeated instructions in self performed plaque control measures. At the end of this preparatory period, each participant receives a full professional tooth cleaning and then abstains from all mechanical tooth cleaning efforts during the course of the next four days. They rinse, however, twice daily, for one minute each time with 10 ml of the test solution. On the fourth day the ten subjects are clinically examined. Immediately following the examinations, they are given professional tooth cleaning and again follow the self performed plaque control measures for 10 days. The participants are then given professional tooth cleaning after which an additional four day test period is initiated. Thus, each person is his own control.
The accounts follow, clearly demonstrating synergistic reduction plaque with Triclosan and PVPA:
______________________________________
Mean
Treatment N Plaque Index/Tooth
% Reduction
______________________________________
Placebo Rinse - A
10 1.46 ± 0.12 --
3% PVPA Rinse - B
10 1.2 ± 0.16 7
0.06% Triclosan
10 0.85 ± 0.20 41
Rinse - C
0.06% Triclosan +
10 0.56 ± 0.18 61*
3% PVPA - D
______________________________________
"N" is Number of participants
*Combination is significantly (P≦0.01) more effective than either
PVPA or Triclosan
The following dentifrice are prepared:
______________________________________
Parts
A B
______________________________________
Glycerine 10.00 --
Propylene Glycol -- 10.00
Sorbitol (70%) 25.00 25.00
Iota carrageenan 0.60 0.60
PVPA (Avg. M.W. 8000)
2.00 2.00
Sodium Saccharin 0.40 0.40
Sodium Fluoride 0.243 0.243
Sodium Hydroxide (50%)
1.00 1.00
Titanium Oxide 0.50 0.50
Silica Polishing Agent
20.00 20.00
(Zeodent 113)
Silica Thickener (Sylox 15)
5.50 5.50
Sodium Lauryl Sulfate
2.00 2.00
Water 31.507 31.507
Triclosan 0.30 0.30
Flavor Oil 0.95 0.95
______________________________________
The following liquid phase dentifrice is prepared:
______________________________________
Ingredients Parts
______________________________________
Sorbitol (70% solution)
30.0
Glycerol 9.5
Propylene Glycol 0.5
SLS 20.0
NaF 0.243
Flavor Oil 0.95
Triclosan 0.3
PVPA (Avg. M.W. 8000)
2.00
Water 56.507
______________________________________
Dentifrices are prepared having the following formulas:
______________________________________
Parts
A B C
______________________________________
Propylene Glycol (1.2)
10.00 10.00 10.00
Iota Carrageenan 0.75 0.75 0.75
PVPA (Avg. M.W. 6000-8000)
2.00 2.00 2.50
Tetrasodium Pyrophosphate
-- 2.00 2.00
Titanium Dioxide 0.50 0.50 0.50
Sorbitol (70%) 30.00 30.00 30.00
Sodium Fluoride 0.332 0.332 0.332
Sodium Saccharin 0.40 0.40 0.40
Silica Thickener (Sylodent 15)
3.00 3.00 3.00
Silica Polishing Agent
20.00 20.00 20.00
(Zeodent 113)
Triclosan 0.20 0.20 0.20
Sodium Lauryl Sulfate
2.00 2.00 2.00
Flavor Oil 0.95 0.95 0.95
Ethyl Alcohol 1.00 1.00 1.00
Water QS to QS to QS to
100.00 100.00 100.00
______________________________________
The following dentifrice is prepared:
______________________________________
Dentifrice
Parts
______________________________________
Propylene Glycol 10.00
Iota Carrageenan 0.60
Sorbitol (70%) 25.00
Sodium Saccharin 0.40
Sodium Fluoride 0.243
Titanium Dioxide 0.50
PVPA (AVG M.W. 6000-8000)
2.00
Water 29.157
NaOH (50%) 2.00
Zeodent 113 (Silica Polishing Agent)
20.00
Sylodent 15 (Silica Thickener)
5.50
Flavor 1.10
Triclosan 0.50
Sodium Lauryl Sulfate 2.00
Ethanol 1.00
______________________________________
The following dentifrice is prepared:
______________________________________
Parts
______________________________________
Propylene Glycol 10.00
Sorbitol (70%) 25.00
Sodium Carboxymethyl Cellulose
0.60
Sodium Saccharin 0.40
Sodium Fluoride 0.243
Silica Polishing Agent
20.00
(Zeodent 113)
Silica Thickener (Sylox 15)
5.50
Water 28.857
PVPA (Avg. M.W. 6000-8000)
2.00
Triclosan 0.30
Titanium Dioxide 0.50
Sodium Lauryl Sulfate 2.50
Flavor 1.10
Ethyl Alcohol 1.00
Sodium Hydroxide (50%)
2.00
______________________________________
Likewise, when other solubilizing agents, particularly dipropylene glycol, hexylene glycol, methyl cellosolve, ethyl cellosolve, olive oil, castor oil, petrolatum, amyl acetate, ethyl acetate, glycerol tristerate and benzyl benzoate, replace propylene glycol, triclosan is effectively delivered to soft oral tissues. Further, similar results are obtained with propylene glycol or other solubilizing agents are omitted from the toothpaste containing 0.3% triclosan.
The following dentifrices are prepared:
______________________________________
Parts
A B
______________________________________
Glycerine -- 20.00
Propylene Glycol 10.00 0.50
Sorbitol (70%) 25.00 19.50
Sodium Carboxymethyl Cellulose
-- 1.10
Iota Carrageenan 0.600 --
Sodium Saccharin 0.40 0.30
Sodium Fluoride 0.243 0.243
Silica Polishing Agent (Zeodent 113)
20.00 20.00
Silica thickener (Sylox 15)
5.50 3.00
Water 28.757 15.307
PVPA (Avg. M.W. 6000-8000)
2.00 2.00
Triclosan 0.50 0.30
Titanium Dioxide 0.50 0.50
Sodium Lauryl Sulfate 2.50 2.00
Flavor 1.10 0.95
Ethanol 1.00 --
Sodium Hydroxide (50%) 2.00 1.60
______________________________________
In the foregoing examples, improved results are also obtained by replacing triclosan with other antibacterial agents herein described, such as phenol, thymol, eugenol and 2,2' methylene bis (4-chloro-6-bromophenol).
The following dentifrices are prepared:
______________________________________
Parts
A B C
______________________________________
Alpha Alumina Trihydrate
48.00 48.00 48.00
Propylene Glycol -- 0.50 0.50
Sorbitol (70%) 21.70 21.70 21.70
PVPA (Avg. M.W. 6000-8000)
2.00 2.00 2.00
Sodium Lauryl Sulfate
2.00 2.13 2.13
Sodium Saccharine 0.30 0.30 0.30
Sodium Hydroxide (50%)
1.20 1.20 1.20
Flavor 0.95 0.95 0.95
Irish Moss 1.00 -- --
Sodium carboxymethyl cellulose
-- 1.00 1.00
Sodium monofluorophosphate
0.76 0.76 0.76
Titanium Dioxide -- 0.50 0.50
Triclosan 0.30 0.30 0.30
Water QS to QS to QS to
100.00 100.00 100.00
______________________________________
The following dentifrices are prepared:
______________________________________
Parts
______________________________________
Glycerine 22.00 10.00
Sorbitol (70%) -- 17.00
Sodium Carboxymethyl cellulose
1.00 1.00
PVPA (Avg. M.W. 6000-8000)
2.00 2.00
Sodium Saccharin 0.20 0.20
Sodium Benzoate 0.50 0.50
Sodium Monofluorophosphate
0.76 0.76
Dicalcium Phosphate Dihydrate
48.76 48.76
Triclosan 0.30 0.30
Sodium Lauryl Sulfate
1.20 1.20
Flavor 0.89 0.89
Water QS to QS to
100.00 100.00
______________________________________
The following antiplaque dentifrice is prepared:
______________________________________
Parts
______________________________________
Glycerine 15.00
Propylene Glycol 2.00
Sodium Carboxymethyl cellulose
1.50
Water 22.69
PVPA (Avg. M.W. 6000-8000)
2.00
Sodium Monofluorophosphate
0.76
Sodium Saccharin 0.30
Insoluble Sodium Metaphosphate
47.00
Titanium Dioxide 0.50
Sodium Lauryl Sulfate 2.00
Triclosan 0.30
Flavor 0.95
______________________________________
In the foregoing examples triclosan can be effectively replaced with each of phenol, 2,2'-methylene bis (4-chloro-6-bromophenol), eugenol and thymol.
Dentifrice Mobile Phase Containing Triclosan
______________________________________
Components Parts
______________________________________
Sorbitol (70%) 50.00 40.00
Water 40.48 50.48
PVPA (Avg. A.W. 6000-8000)
2.00 2.00
NaOH (50%) 1.33 1.33
Saccharin 0.40 0.40
Sodium Fluoride 0.32 0.32
Flavor Oil 1.47 1.47
Sodium Lauryl Sulfate 3.33 3.33
Triclosan 0.67 0.67
______________________________________
The concentration of the above mobile phases are 75% of finished dentifrice level to reflect 25% level of polishing agent to make a complete dentifrice.
The mouthrinses below are prepared:
______________________________________
A B C D E
Parts Parts Parts Parts Parts
______________________________________
PVPA (Avg. M.W.
0.25 0.25 0.25 0.25 0.25
6000-8000)
Glycerine 15.00 10.00 15.00 10.00 15.00
Ethanol -- -- 12.50 12.50 --
Propylene Glycol
-- 5.00 -- 5.00 --
Pluronic F108-
2.00 2.00 2.00 2.00 2.00
(Polyoxhtylene/Poly-
oxypropoylene Block
Copolymer)
Sodium Lauryl Sulfate
-- -- 0.20 0.20 0.20
Triclosan 0.10 0.10 0.06 0.06 0.03
Flavoring Oil
0.40 0.40 0.40 0.40 0.40
Water QS to QS to QS to QS to QS to
100.00 100.00 100.00
100.00
100.00
______________________________________
The following liquid dentifrices are prepared:
______________________________________
A B C
Parts Parts Parts
______________________________________
Glycerine 20.0 20.0 --
PVPA (Avg. M.W. 6000--8000)
0.3 0.3 0.3
Polysaccharide of high molecular
0.8 -- 1.0
weight, the molecule containing
mannose, glucose, potassium
glucuronate and acetyl moieties
in the approximate molar ratio
of 2:1:1:1
Sodium benzoate 0.5 0.5 0.5
Saccharine sodium 0.5 0.5 0.5
Water 61.3 73.1 71.6
Sodium lauryl sulfate
3.0 3.0 3.0
Insoluble sodium metaphosphate
10.0 -- 10.0
Anhydrous dicalcium phosphate
1.0 -- 2.5
Flavoring Oil 2.5 2.5 2.5
Ethyl alcohol -- -- 10.0
Triclosan 0.1 0.1 0.1
______________________________________
In the foregoing Examples, improved results are also achieved when triclosan is replaced with each of phenol, 2,2'-methylene bis (4-chloro-6-bromophenol), eugenol and thymol.
This invention has been described with respect to certain preferred embodiments and it will be understood that modifications and variations thereof obvious to those skilled in the art are to be included within the preview of this application and the scope of the appended claims.
Claims (25)
1. An oral composition comprising an effective antiplaque amount of about 0.01%-5% of a substantially water insoluble noncationic antibacterial agent, 0.005%-4% by weight of polyvinyl phosphonate having recurring groups ##STR3## and average molecular weight of at least about 1,000 wherein M and M1 are hydrogen alkali metal or ammonium and wherein M and M1 are the same or different, and an orally acceptable vehicle comprising at least one of a surface-active agent or a flavoring oil effective to enable the said antibacterial agent to dissolve in saliva in effective antiplaque amount, said polyvinyl phosphonate enhancing the antibacterial effect of said antibacterial agent to inhibit plaque formation.
2. The oral composition claim in claim 1, in which the said oral composition is a dentifrice comprising about 5-30% by weight of a siliceous polishing agent and the said antibacterial agent is present in amount of about 0.25-0.35% by weight.
3. The oral composition claimed in claim 1, in which the said oral composition is a dentifrice comprising about 5-30% by weight of a siliceous polishing agent, the said antibacterial agent is present in amount of about 0.01-5% by weight and the said oral composition comprises a solubilizing material in amount to assist dissolving the said antibacterial agent in saliva.
4. The oral composition claimed in claim 3, in which the said antibacterial agent is present in amount of about 0.05% up to below about 0.25% by weight.
5. The oral composition claimed in claim 3, in which the said antibacterial agent is present in amount of above about 0.35% up to about 5% by weight.
6. The oral composition claimed in claim 5, in which the said antibacterial agent is present in amount of above about 0.35% up to about 0.5% by weight.
7. The oral composition claimed in any one of claims 1 to 6 in which the said oral composition is a dentifrice comprising about 30-75% by weight of a dentally acceptable water-insoluble polishing agent.
8. The oral composition claimed in claim 1, in which the said oral composition is a mouthwash or liquid dentifrice and the said orally acceptable vehicle is an aqueous vehicle wherein there is present a non-toxic alcohol.
9. The oral composition claimed 1 in which there is present surface-active agent in amount of about 0.5-5% by weight.
10. The oral composition claimed 1 in which there is present flavoring oil in amount of about 0.1-5% by weight.
11. The oral composition claimed in claim 8 in which the said composition is a mouthwash and the said aqueous vehicle contains ethanol and the weight ratio of water to ethanol is from about 1:1 to about 20:1.
12. The oral composition claimed in claim 8 or claim 11 in which the said oral composition is a liquid dentifrice containing about 0.3-2 0% by weight of a polysaccharide of high molecular weight in excess of 1,000,000 containing mannose, glucose, potassium glucuronate and acetyl moieties in the approximate ratio of 2:1:1:1, as suspending and thickening agent and about 10-20% by weight of a polishing material.
13. The oral composition claimed in any one of claims 1 to 12 in which the said antibacterial agent is selected form the group consisting of halogenated diphenyl ethers, halogenated salicylanilides, benzoic esters, halogenated carbanilides and phenolic compounds.
14. The oral composition claimed in claim 13 in which the said antibacterial agent is a halogenated diphenyl ether.
15. The oral composition claimed in claim 14 in which the said halogenated diphenyl ether is 2,4,4'-trichloro-2"-hydroxyphenyl ether.
16. The oral composition claimed in any one of claims 1 to 15 in which a solubilizing agent is present in amount of about 0.5 to 50% by weight and is selected from the group consisting of propylene glycol, dipropylene glycol, hexylene glycol, methyl cellosolve, ethyl cellosolve, vegetable oil and was containing at least about 12 carbon atoms, amyl acetate, ethyl acetate, glyceryl tristerate and benzyl benzoate.
17. The oral composition dentifrice claimed in claim 16 in which the solubilizing agent is propylene glycol and is present in amount of about 0.5% by weight.
18. The oral composition in the form of a dentifrice claimed claim 1 wherein about 30-70% by weight of a polishing agent is present which is selected from the group consisting of sodium metaphosphate, tri-calcium phosphate, dihydrated dicalcium phosphate, anhydrous dicalcium phosphate, anhydrous dicalcium phosphate, calcium pyrophosphate, magnesium orthophosphate, trimagnesium phosphate, calcium carbonate, aluminum silicate, hydrated alumina, silica, bentonite and mixtures thereof.
19. The oral composition dentifrice claimed in claim 18 wherein said polishing agent is dicalcium phosphate dihydrate or hydrated alumina.
20. The oral composition claimed in any one of claims 1 to 19 wherein said polyvinyl phosphonate has an average molecular weight of about 1,000 to about 1,000,000 and is present in amount of about 0.005-4% by weight.
21. The oral composition claimed in claim 20 in which the said PVPA copolymer has a molecular weight of about 6,000 to about 100,000.
22. The oral composition claimed in claim 21 in which said PVPA copolymer was a molecular weight of about 6,000 to about 8,000.
23. The oral composition claimed in claim 20 said polyvinyl phosphonate is present in amount of about 0.05-3% by weight.
24. A composition claimed in claim 23 in which said polyvinyl phosphonate is present in amount of about 0.1-2.5% by weight.
25. A method of inhibiting dental plaque comprising applying to tooth and soft gum surfaces the oral composition claimed in any one of claims 1 to 19.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/925,363 US5296214A (en) | 1989-08-25 | 1992-08-04 | Anticalculus composition |
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39860589A | 1989-08-25 | 1989-08-25 | |
| US39966989A | 1989-08-25 | 1989-08-25 | |
| US39860689A | 1989-08-25 | 1989-08-25 | |
| US07/398,592 US5188821A (en) | 1987-01-30 | 1989-08-25 | Antibacterial antiplaque oral composition mouthwash or liquid dentifrice |
| US07/398,566 US5032386A (en) | 1988-12-29 | 1989-08-25 | Antiplaque antibacterial oral composition |
| US07/655,571 US5178851A (en) | 1987-01-30 | 1991-02-14 | Antiplaque antibacterial oral composition |
| US07/657,885 US5180578A (en) | 1987-01-30 | 1991-02-19 | Antibacterial antiplaque anticalculus oral composition |
| US07/754,887 US5192530A (en) | 1987-01-30 | 1991-09-06 | Antibacterial antiplaque oral composition |
| US07/758,345 US5192531A (en) | 1988-12-29 | 1991-09-09 | Antibacterial antiplaque oral composition |
| US07/925,363 US5296214A (en) | 1989-08-25 | 1992-08-04 | Anticalculus composition |
Related Parent Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/398,592 Continuation-In-Part US5188821A (en) | 1987-01-30 | 1989-08-25 | Antibacterial antiplaque oral composition mouthwash or liquid dentifrice |
| US07/655,571 Continuation-In-Part US5178851A (en) | 1987-01-30 | 1991-02-14 | Antiplaque antibacterial oral composition |
| US07/657,885 Continuation-In-Part US5180578A (en) | 1987-01-30 | 1991-02-19 | Antibacterial antiplaque anticalculus oral composition |
| US07/754,887 Continuation-In-Part US5192530A (en) | 1987-01-30 | 1991-09-06 | Antibacterial antiplaque oral composition |
| US07/758,345 Continuation-In-Part US5192531A (en) | 1987-01-30 | 1991-09-09 | Antibacterial antiplaque oral composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US5296214A true US5296214A (en) | 1994-03-22 |
Family
ID=23575869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US07/925,363 Expired - Lifetime US5296214A (en) | 1989-08-25 | 1992-08-04 | Anticalculus composition |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US5296214A (en) |
| HU (1) | HU9300151D0 (en) |
| IT (1) | IT1241168B (en) |
| ZM (1) | ZM5189A1 (en) |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5424059A (en) * | 1988-12-29 | 1995-06-13 | Colgate Palmolive Company | Antibacterial antiplaque dentifrice |
| US5472684A (en) * | 1993-06-02 | 1995-12-05 | Colgate Palmolive Company | Oral compositions for plaque and gingivitis |
| US5686063A (en) * | 1994-06-10 | 1997-11-11 | The Procter & Gamble Company | Mouthrinse compositions |
| US5686064A (en) * | 1987-01-30 | 1997-11-11 | Colgate Palmolive Company | Antibacterial antiplaque, anticalculus oral composition |
| US5733530A (en) * | 1993-12-29 | 1998-03-31 | The Procter & Gamble Company | Tartar control dentifrice composition containing thymol |
| US5840281A (en) * | 1993-01-07 | 1998-11-24 | Colgate Palmolive Company | Oral composition |
| US5843406A (en) * | 1998-01-12 | 1998-12-01 | Colgate Palmolive Company | Dual components antiplaque dentifrice compositions |
| US6159446A (en) * | 1998-03-06 | 2000-12-12 | Fmc Corporation | High moisture toothpaste |
| US6162418A (en) * | 1998-03-06 | 2000-12-19 | Fmc Corporation | Non-stringy toothpaste |
| US6241974B1 (en) * | 1997-04-22 | 2001-06-05 | The Procter & Gamble Company | Dentifrice compositions containing β-phase calcium pyrophosphate an anticalculus agent, and fluoride |
| US6280707B1 (en) | 1998-12-15 | 2001-08-28 | Dentsply International Inc. | Oral prophalaxis paste |
| EP1428518A2 (en) | 2002-12-12 | 2004-06-16 | Colgate-Palmolive Company | Method for optimizing fluoride uptake of teeth by applying a liquid dentifrice composition |
| US20040126335A1 (en) * | 1999-11-12 | 2004-07-01 | The Procter & Gamble Company | Method of enhancing fluoridation and mineralization of teeth |
| US20050271602A1 (en) * | 2004-06-02 | 2005-12-08 | Nebojsa Milanovich | Method for inhibiting chemical staining of teeth |
| US20050271601A1 (en) * | 2004-06-02 | 2005-12-08 | Nebojsa Milanovich | Anti-staining antibacterial dentifrice |
| US20060257332A1 (en) * | 2005-05-13 | 2006-11-16 | Pierro Francesco D | Anticaries compositions containing phaseolamin |
| US20070009447A1 (en) * | 2003-02-05 | 2007-01-11 | Gadkari Vijay K | Toothpaste compositions with reduced abrasivity |
| US20070041914A1 (en) * | 2005-08-17 | 2007-02-22 | Colgate-Palmolive Company | Inhibition of bacterial deposition on oral surfaces |
| US20070083998A1 (en) * | 2005-10-13 | 2007-04-19 | Leskowicz James J | Deodorizing compositions |
| US20070083999A1 (en) * | 2005-10-13 | 2007-04-19 | Leskowicz James J | Deodorizing compositions |
| US10258550B2 (en) | 1999-11-12 | 2019-04-16 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US10470985B2 (en) | 1999-11-12 | 2019-11-12 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US10596086B2 (en) | 2012-06-21 | 2020-03-24 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antibacterials |
| US10751260B2 (en) | 2013-10-22 | 2020-08-25 | Jag Mayer Pty Ltd | Dispenser |
| US11191709B2 (en) | 2019-04-26 | 2021-12-07 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2090265A (en) * | 1980-12-31 | 1982-07-07 | Colgate Palmolive Co | Antigingivitis activity |
| US4427652A (en) * | 1980-12-31 | 1984-01-24 | Colgate-Palmolive Company | Antigingivitis composition |
| GB2151478A (en) * | 1983-12-28 | 1985-07-24 | Colgate Palmolive Co | Antiplaque/antigingivitis compositions |
| US4816245A (en) * | 1983-12-28 | 1989-03-28 | Colgate-Palmolive Company | Antiplaque/antigingivitis method using certain polyphosphonic acids |
| GB2224204A (en) * | 1988-10-25 | 1990-05-02 | Colgate Palmolive Co | Antiplaque/antigingivitis composition |
| US5208009A (en) * | 1990-12-20 | 1993-05-04 | Colgate-Palmolive Company | Anticalculus oral compositions |
-
1989
- 1989-12-18 ZM ZM51/89A patent/ZM5189A1/en unknown
- 1989-12-22 IT IT48697A patent/IT1241168B/en active IP Right Grant
- 1989-12-28 HU HU9300151A patent/HU9300151D0/en unknown
-
1992
- 1992-08-04 US US07/925,363 patent/US5296214A/en not_active Expired - Lifetime
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2090265A (en) * | 1980-12-31 | 1982-07-07 | Colgate Palmolive Co | Antigingivitis activity |
| US4342857A (en) * | 1980-12-31 | 1982-08-03 | Colgate-Palmolive Company | Antigingivitis composition comprising vinyl phosphonic acid/vinyl phosphonyl fluoride copolymer |
| US4427652A (en) * | 1980-12-31 | 1984-01-24 | Colgate-Palmolive Company | Antigingivitis composition |
| GB2151478A (en) * | 1983-12-28 | 1985-07-24 | Colgate Palmolive Co | Antiplaque/antigingivitis compositions |
| US4816245A (en) * | 1983-12-28 | 1989-03-28 | Colgate-Palmolive Company | Antiplaque/antigingivitis method using certain polyphosphonic acids |
| GB2224204A (en) * | 1988-10-25 | 1990-05-02 | Colgate Palmolive Co | Antiplaque/antigingivitis composition |
| US5208009A (en) * | 1990-12-20 | 1993-05-04 | Colgate-Palmolive Company | Anticalculus oral compositions |
Cited By (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686064A (en) * | 1987-01-30 | 1997-11-11 | Colgate Palmolive Company | Antibacterial antiplaque, anticalculus oral composition |
| US5424059A (en) * | 1988-12-29 | 1995-06-13 | Colgate Palmolive Company | Antibacterial antiplaque dentifrice |
| US5840281A (en) * | 1993-01-07 | 1998-11-24 | Colgate Palmolive Company | Oral composition |
| US5472684A (en) * | 1993-06-02 | 1995-12-05 | Colgate Palmolive Company | Oral compositions for plaque and gingivitis |
| US5733530A (en) * | 1993-12-29 | 1998-03-31 | The Procter & Gamble Company | Tartar control dentifrice composition containing thymol |
| US5686063A (en) * | 1994-06-10 | 1997-11-11 | The Procter & Gamble Company | Mouthrinse compositions |
| US6241974B1 (en) * | 1997-04-22 | 2001-06-05 | The Procter & Gamble Company | Dentifrice compositions containing β-phase calcium pyrophosphate an anticalculus agent, and fluoride |
| US5843406A (en) * | 1998-01-12 | 1998-12-01 | Colgate Palmolive Company | Dual components antiplaque dentifrice compositions |
| US6162418A (en) * | 1998-03-06 | 2000-12-19 | Fmc Corporation | Non-stringy toothpaste |
| US6159446A (en) * | 1998-03-06 | 2000-12-12 | Fmc Corporation | High moisture toothpaste |
| US6280707B1 (en) | 1998-12-15 | 2001-08-28 | Dentsply International Inc. | Oral prophalaxis paste |
| US7387774B2 (en) | 1999-11-12 | 2008-06-17 | The Procter & Gamble Co. | Method of enhancing fluoridation and mineralization of teeth |
| US10702460B2 (en) | 1999-11-12 | 2020-07-07 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US10470985B2 (en) | 1999-11-12 | 2019-11-12 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US20040126335A1 (en) * | 1999-11-12 | 2004-07-01 | The Procter & Gamble Company | Method of enhancing fluoridation and mineralization of teeth |
| US10376451B2 (en) | 1999-11-12 | 2019-08-13 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US10369090B2 (en) | 1999-11-12 | 2019-08-06 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US10258549B2 (en) | 1999-11-12 | 2019-04-16 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| US10258550B2 (en) | 1999-11-12 | 2019-04-16 | The Procter & Gamble Company | Method of protecting teeth against erosion |
| EP1428518A2 (en) | 2002-12-12 | 2004-06-16 | Colgate-Palmolive Company | Method for optimizing fluoride uptake of teeth by applying a liquid dentifrice composition |
| AU2010200546B2 (en) * | 2002-12-12 | 2012-10-18 | Colgate-Palmolive Company | Method for optimizing fluoride uptake of teeth by applying a liquid dentifrice composition |
| US20040115140A1 (en) * | 2002-12-12 | 2004-06-17 | Joziak Marilou T. | Liquid dentifrice compositions of optimized fluoride uptake |
| WO2004054530A1 (en) * | 2002-12-12 | 2004-07-01 | Colgate-Palmolive Company | Method for optimizing fluoride uptake of teeth by applying a liquid dentifrice composition |
| EP1428518A3 (en) * | 2002-12-12 | 2004-07-07 | Colgate-Palmolive Company | Method for optimizing fluoride uptake of teeth by applying a liquid dentifrice composition |
| CN100415201C (en) * | 2002-12-12 | 2008-09-03 | 高露洁-棕榄公司 | Method of optimizing fluoride absorption by teeth by administering a liquid dentifrice composition |
| US20070009447A1 (en) * | 2003-02-05 | 2007-01-11 | Gadkari Vijay K | Toothpaste compositions with reduced abrasivity |
| US9072658B2 (en) | 2003-02-05 | 2015-07-07 | Fmc Corporation | Toothpaste compositions with reduced abrasivity |
| US20050271601A1 (en) * | 2004-06-02 | 2005-12-08 | Nebojsa Milanovich | Anti-staining antibacterial dentifrice |
| US20050271602A1 (en) * | 2004-06-02 | 2005-12-08 | Nebojsa Milanovich | Method for inhibiting chemical staining of teeth |
| US20060257332A1 (en) * | 2005-05-13 | 2006-11-16 | Pierro Francesco D | Anticaries compositions containing phaseolamin |
| US20070041914A1 (en) * | 2005-08-17 | 2007-02-22 | Colgate-Palmolive Company | Inhibition of bacterial deposition on oral surfaces |
| RU2383330C2 (en) * | 2005-08-17 | 2010-03-10 | Колгейт-Палмолив Компани | Inhibition of bacteria adhesion on oral cavity surfaces |
| AU2006279628B2 (en) * | 2005-08-17 | 2010-02-18 | Colgate-Palmolive Company | Inhibition of bacterial deposition on oral surfaces |
| WO2007022167A1 (en) * | 2005-08-17 | 2007-02-22 | Colgate-Palmolive Company | Inhibition of bacterial deposition on oral surfaces |
| US7407515B2 (en) | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| US7407922B2 (en) | 2005-10-13 | 2008-08-05 | S.C. Johnson & Son, Inc. | Deodorizing compositions |
| US7261742B2 (en) | 2005-10-13 | 2007-08-28 | S.C. Johnson & Son, Inc. | Method of deodorizing a textile |
| US20070083999A1 (en) * | 2005-10-13 | 2007-04-19 | Leskowicz James J | Deodorizing compositions |
| US20070083998A1 (en) * | 2005-10-13 | 2007-04-19 | Leskowicz James J | Deodorizing compositions |
| US10596086B2 (en) | 2012-06-21 | 2020-03-24 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antibacterials |
| US11253451B2 (en) | 2012-06-21 | 2022-02-22 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antibacterials |
| US10751260B2 (en) | 2013-10-22 | 2020-08-25 | Jag Mayer Pty Ltd | Dispenser |
| US11191709B2 (en) | 2019-04-26 | 2021-12-07 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
| US11826452B2 (en) | 2019-04-26 | 2023-11-28 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
Also Published As
| Publication number | Publication date |
|---|---|
| IT8948697A1 (en) | 1991-06-22 |
| ZM5189A1 (en) | 1990-07-27 |
| IT8948697A0 (en) | 1989-12-22 |
| IT1241168B (en) | 1993-12-29 |
| HU9300151D0 (en) | 1993-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5296214A (en) | Anticalculus composition | |
| EP0696449B1 (en) | Antimicrobial oral composition | |
| US5156835A (en) | Antibacterial antiplaque oral composition | |
| FI97329C (en) | Antibacterial oral composition counteracts the onset of plaque and tartar | |
| AU654874B2 (en) | Antiplaque antibacterial oral composition | |
| US5424059A (en) | Antibacterial antiplaque dentifrice | |
| US5043154A (en) | Antibacterial, antiplaque, anticalculus oral composition | |
| US5256401A (en) | Antibacterial antiplaque mouthwash composition | |
| US5188821A (en) | Antibacterial antiplaque oral composition mouthwash or liquid dentifrice | |
| US5037637A (en) | Antibacterial antiplaque, anticalculus oral composition | |
| US5288480A (en) | Antiplaque antibacterial oral composition | |
| US5294431A (en) | Antibacterial antiplaque oral composition mouthwash or liquid dentifrice | |
| US5080887A (en) | Antibacterial antiplaque, anticalculus oral composition | |
| IL92694A (en) | Antibacterial antiplaque anticalculus oral composition | |
| EP0693919B1 (en) | Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt | |
| US5178851A (en) | Antiplaque antibacterial oral composition | |
| US5445814A (en) | Methods for making oral compositions | |
| US4590064A (en) | Anticalculus oral composition | |
| US5681548A (en) | Oral formulations | |
| US4880619A (en) | Anticalculus oral composition | |
| US5290542A (en) | Oral compositions for treating plaque and gingivitis | |
| US6692725B2 (en) | Composition for oral care | |
| EP0692246B1 (en) | Use of oral compositions for reducing plaque formation on the teeth | |
| US5453265A (en) | Antibacterial antiplaque oral composition | |
| US5312618A (en) | Antibacterial antiplaque oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: COLGATE-PALMOLIVE CO., NEW JERSEY Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GAFFAR, ABDUL;REEL/FRAME:006633/0568 Effective date: 19930804 |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| FPAY | Fee payment |
Year of fee payment: 4 |
|
| FPAY | Fee payment |
Year of fee payment: 8 |
|
| FPAY | Fee payment |
Year of fee payment: 12 |